{
    "paper_id": "PMC7171713",
    "metadata": {
        "title": "Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention",
        "authors": [
            {
                "first": "Joseph",
                "middle": [
                    "P."
                ],
                "last": "Lynch",
                "suffix": "III",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Adriana",
                "middle": [
                    "E."
                ],
                "last": "Kajon",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "In 2011, we published a comprehensive review of adenovirus (AdV) infections in this journal1; this article updates new developments since that review. AdVs most often infect the upper or lower respiratory tracts, conjunctiva, or gastrointestinal (GI) tract.1\n2\n3\n4 More than 80% of diagnosed AdV infections occur in children < 4 years old (due to lack of humoral immunity).2\n3\n5\n6 Immunosuppressed persons2\n7\n8\n9 are more susceptible.3\n10\n11\n12\n13\n14\n15 High baseline immunity against AdV (IgG titer of \u2265 1:32) confers substantial protection.16 AdV infections may occur in healthy children3\n10\n11\n12\n13 or adults in closed or crowded settings (particularly military recruits).17\n18\n19\n20\n21 The vast majority of cases are self-limited. However, the clinical spectrum is broad, and dissemination or pneumonia can be fatal, both in immunocompetent22\n23 and immunocompromised patients.2\n9\n24\n25\n26\n27\n28\n",
            "cite_spans": [
                {
                    "start": 91,
                    "end": 92,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 257,
                    "end": 258,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 259,
                    "end": 260,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 261,
                    "end": 262,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 263,
                    "end": 264,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 373,
                    "end": 374,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 375,
                    "end": 376,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 377,
                    "end": 378,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 379,
                    "end": 380,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 405,
                    "end": 406,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 407,
                    "end": 408,
                    "mention": "7",
                    "ref_id": "BIBREF293"
                },
                {
                    "start": 409,
                    "end": 410,
                    "mention": "8",
                    "ref_id": "BIBREF304"
                },
                {
                    "start": 411,
                    "end": 412,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 434,
                    "end": 435,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 436,
                    "end": 438,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 439,
                    "end": 441,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 442,
                    "end": 444,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 445,
                    "end": 447,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 448,
                    "end": 450,
                    "mention": "14",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 451,
                    "end": 453,
                    "mention": "15",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 542,
                    "end": 544,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 589,
                    "end": 590,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 591,
                    "end": 593,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 594,
                    "end": 596,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 597,
                    "end": 599,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 600,
                    "end": 602,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 676,
                    "end": 678,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 679,
                    "end": 681,
                    "mention": "18",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 682,
                    "end": 684,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 685,
                    "end": 687,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 688,
                    "end": 690,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 845,
                    "end": 847,
                    "mention": "22",
                    "ref_id": "BIBREF137"
                },
                {
                    "start": 848,
                    "end": 850,
                    "mention": "23",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 882,
                    "end": 883,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 884,
                    "end": 885,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 886,
                    "end": 888,
                    "mention": "24",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 889,
                    "end": 891,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 892,
                    "end": 894,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 895,
                    "end": 897,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 898,
                    "end": 900,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                }
            ],
            "section": "Adenovirus",
            "ref_spans": []
        },
        {
            "text": "Human AdVs are a group of double-stranded nonenveloped DNA viruses belonging to the genus Mastadenovirus of the Adenoviridae family.29\n30 Currently, 51 serotypes, and over 70 genotypes defined by bioinformatics analysis of complete genomic sequences and designated with consecutive numbers (52, 53, 54, etc.) have been described and classified within 7 species (HAdV-A through HAdV-G).31\n32\n33\n34\n35\n36\n37 Species A, B, C, D, E, and F circulate globally, and have been implicated in outbreaks of infection in humans.1 Different genome types (or genomic variants) can be distinguished within the same serotype by restriction enzyme analysis of genomic DNA.38\n39\n40 Approximately one-third of the described serotypes are associated with human disease.24\n26\n29\n31\n41\n42\n43\n44 Different serotypes display different tissue tropisms that correlate with clinical manifestations of infection2\n26\n31\n33 (discussed in detail in the next sections).",
            "cite_spans": [
                {
                    "start": 132,
                    "end": 134,
                    "mention": "29",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 135,
                    "end": 137,
                    "mention": "30",
                    "ref_id": "BIBREF224"
                },
                {
                    "start": 385,
                    "end": 387,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 388,
                    "end": 390,
                    "mention": "32",
                    "ref_id": "BIBREF246"
                },
                {
                    "start": 391,
                    "end": 393,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 394,
                    "end": 396,
                    "mention": "34",
                    "ref_id": "BIBREF254"
                },
                {
                    "start": 397,
                    "end": 399,
                    "mention": "35",
                    "ref_id": "BIBREF255"
                },
                {
                    "start": 400,
                    "end": 402,
                    "mention": "36",
                    "ref_id": "BIBREF256"
                },
                {
                    "start": 403,
                    "end": 405,
                    "mention": "37",
                    "ref_id": "BIBREF257"
                },
                {
                    "start": 516,
                    "end": 517,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 658,
                    "end": 660,
                    "mention": "39",
                    "ref_id": "BIBREF259"
                },
                {
                    "start": 661,
                    "end": 663,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 749,
                    "end": 751,
                    "mention": "24",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 752,
                    "end": 754,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 755,
                    "end": 757,
                    "mention": "29",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 758,
                    "end": 760,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 761,
                    "end": 763,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                },
                {
                    "start": 764,
                    "end": 766,
                    "mention": "42",
                    "ref_id": "BIBREF263"
                },
                {
                    "start": 767,
                    "end": 769,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 770,
                    "end": 772,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 883,
                    "end": 884,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 885,
                    "end": 887,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 888,
                    "end": 890,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 891,
                    "end": 893,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                }
            ],
            "section": "Virology",
            "ref_spans": []
        },
        {
            "text": "AdVs may cause epidemics of febrile respiratory illness (FRI), pharyngoconjunctival fever,45 keratoconjunctivitis (KC),46\n47\n48\n49 or gastroenteritis and diarrheal illness.50\n51\n52\n53\n54\n55\n56\n57\n58\n59\n60\n61 Severe or disseminated AdV infections may occur in immunocompromised hosts7\n9\n62\n63\n64 and rarely in immunocompetent patients.23\n65\n",
            "cite_spans": [
                {
                    "start": 90,
                    "end": 92,
                    "mention": "45",
                    "ref_id": "BIBREF266"
                },
                {
                    "start": 119,
                    "end": 121,
                    "mention": "46",
                    "ref_id": "BIBREF267"
                },
                {
                    "start": 122,
                    "end": 124,
                    "mention": "47",
                    "ref_id": "BIBREF268"
                },
                {
                    "start": 125,
                    "end": 127,
                    "mention": "48",
                    "ref_id": "BIBREF269"
                },
                {
                    "start": 128,
                    "end": 130,
                    "mention": "49",
                    "ref_id": "BIBREF270"
                },
                {
                    "start": 172,
                    "end": 174,
                    "mention": "50",
                    "ref_id": "BIBREF272"
                },
                {
                    "start": 175,
                    "end": 177,
                    "mention": "51",
                    "ref_id": "BIBREF273"
                },
                {
                    "start": 178,
                    "end": 180,
                    "mention": "52",
                    "ref_id": "BIBREF274"
                },
                {
                    "start": 181,
                    "end": 183,
                    "mention": "53",
                    "ref_id": "BIBREF275"
                },
                {
                    "start": 184,
                    "end": 186,
                    "mention": "54",
                    "ref_id": "BIBREF276"
                },
                {
                    "start": 187,
                    "end": 189,
                    "mention": "55",
                    "ref_id": "BIBREF277"
                },
                {
                    "start": 190,
                    "end": 192,
                    "mention": "56",
                    "ref_id": "BIBREF278"
                },
                {
                    "start": 193,
                    "end": 195,
                    "mention": "57",
                    "ref_id": "BIBREF279"
                },
                {
                    "start": 196,
                    "end": 198,
                    "mention": "58",
                    "ref_id": "BIBREF280"
                },
                {
                    "start": 199,
                    "end": 201,
                    "mention": "59",
                    "ref_id": "BIBREF281"
                },
                {
                    "start": 202,
                    "end": 204,
                    "mention": "60",
                    "ref_id": "BIBREF283"
                },
                {
                    "start": 205,
                    "end": 207,
                    "mention": "61",
                    "ref_id": "BIBREF284"
                },
                {
                    "start": 282,
                    "end": 283,
                    "mention": "7",
                    "ref_id": "BIBREF293"
                },
                {
                    "start": 284,
                    "end": 285,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 286,
                    "end": 288,
                    "mention": "62",
                    "ref_id": "BIBREF285"
                },
                {
                    "start": 289,
                    "end": 291,
                    "mention": "63",
                    "ref_id": "BIBREF286"
                },
                {
                    "start": 292,
                    "end": 294,
                    "mention": "64",
                    "ref_id": "BIBREF287"
                },
                {
                    "start": 334,
                    "end": 336,
                    "mention": "23",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 337,
                    "end": 339,
                    "mention": "65",
                    "ref_id": "BIBREF288"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "Most epidemics occur in the winter or early spring,6 but infections occur throughout the year with no clear seasonality.2 Infection can result from exposure to infected individuals (inhalation of aerosolized droplets, conjunctival inoculation, fecal oral spread),1\n2\n66\n67 acquisition from exogenous sources (e.g., pillows, linens, lockers, guns),68\n69 or reactivation.2\n26 Incubation period ranges from 2 to 14 days.2 Importantly, latent AdV may reside in lymphoid tissue,7\n70 renal parenchyma,71 or other tissues for years; reactivation may occur in severely immunosuppressed patients.7\n70\n71 Asymptomatic carriage of AdV may persist for weeks or months.31\n72\n73 Epidemics may spread rapidly among closed populations16\n17\n20\n33\n40\n44\n68\n74\n75\n76 (e.g., hospitals,6\n67\n77 neonatal nurseries,78 psychiatric77\n79 or long-term care facilities,48\n66\n80 job training centers,21 boarding schools or dormitories,81 a children's home,82 orphanages,83 public swimming pools84\n85). In institutionalized settings, infection control measures and cohorting may be essential to limit spread.66\n67\n86 AdV is resistant to many disinfectants87 but 95% ethanol solution is an effective disinfectant.73\n",
            "cite_spans": [
                {
                    "start": 51,
                    "end": 52,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 120,
                    "end": 121,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 263,
                    "end": 264,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 265,
                    "end": 266,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 267,
                    "end": 269,
                    "mention": "66",
                    "ref_id": "BIBREF289"
                },
                {
                    "start": 270,
                    "end": 272,
                    "mention": "67",
                    "ref_id": "BIBREF290"
                },
                {
                    "start": 347,
                    "end": 349,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 350,
                    "end": 352,
                    "mention": "69",
                    "ref_id": "BIBREF292"
                },
                {
                    "start": 369,
                    "end": 370,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 371,
                    "end": 373,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 417,
                    "end": 418,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 473,
                    "end": 474,
                    "mention": "7",
                    "ref_id": "BIBREF293"
                },
                {
                    "start": 475,
                    "end": 477,
                    "mention": "70",
                    "ref_id": "BIBREF294"
                },
                {
                    "start": 495,
                    "end": 497,
                    "mention": "71",
                    "ref_id": "BIBREF295"
                },
                {
                    "start": 587,
                    "end": 588,
                    "mention": "7",
                    "ref_id": "BIBREF293"
                },
                {
                    "start": 589,
                    "end": 591,
                    "mention": "70",
                    "ref_id": "BIBREF294"
                },
                {
                    "start": 592,
                    "end": 594,
                    "mention": "71",
                    "ref_id": "BIBREF295"
                },
                {
                    "start": 656,
                    "end": 658,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 659,
                    "end": 661,
                    "mention": "72",
                    "ref_id": "BIBREF296"
                },
                {
                    "start": 662,
                    "end": 664,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                },
                {
                    "start": 718,
                    "end": 720,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 721,
                    "end": 723,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 724,
                    "end": 726,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 727,
                    "end": 729,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 730,
                    "end": 732,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 733,
                    "end": 735,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 736,
                    "end": 738,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 739,
                    "end": 741,
                    "mention": "74",
                    "ref_id": "BIBREF298"
                },
                {
                    "start": 742,
                    "end": 744,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 745,
                    "end": 747,
                    "mention": "76",
                    "ref_id": "BIBREF300"
                },
                {
                    "start": 765,
                    "end": 766,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 767,
                    "end": 769,
                    "mention": "67",
                    "ref_id": "BIBREF290"
                },
                {
                    "start": 770,
                    "end": 772,
                    "mention": "77",
                    "ref_id": "BIBREF301"
                },
                {
                    "start": 792,
                    "end": 794,
                    "mention": "78",
                    "ref_id": "BIBREF302"
                },
                {
                    "start": 806,
                    "end": 808,
                    "mention": "77",
                    "ref_id": "BIBREF301"
                },
                {
                    "start": 809,
                    "end": 811,
                    "mention": "79",
                    "ref_id": "BIBREF303"
                },
                {
                    "start": 841,
                    "end": 843,
                    "mention": "48",
                    "ref_id": "BIBREF269"
                },
                {
                    "start": 844,
                    "end": 846,
                    "mention": "66",
                    "ref_id": "BIBREF289"
                },
                {
                    "start": 847,
                    "end": 849,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 871,
                    "end": 873,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 906,
                    "end": 908,
                    "mention": "81",
                    "ref_id": "BIBREF306"
                },
                {
                    "start": 927,
                    "end": 929,
                    "mention": "82",
                    "ref_id": "BIBREF307"
                },
                {
                    "start": 941,
                    "end": 943,
                    "mention": "83",
                    "ref_id": "BIBREF308"
                },
                {
                    "start": 965,
                    "end": 967,
                    "mention": "84",
                    "ref_id": "BIBREF309"
                },
                {
                    "start": 968,
                    "end": 970,
                    "mention": "85",
                    "ref_id": "BIBREF310"
                },
                {
                    "start": 1078,
                    "end": 1080,
                    "mention": "66",
                    "ref_id": "BIBREF289"
                },
                {
                    "start": 1081,
                    "end": 1083,
                    "mention": "67",
                    "ref_id": "BIBREF290"
                },
                {
                    "start": 1084,
                    "end": 1086,
                    "mention": "86",
                    "ref_id": "BIBREF311"
                },
                {
                    "start": 1125,
                    "end": 1127,
                    "mention": "87",
                    "ref_id": "BIBREF312"
                },
                {
                    "start": 1182,
                    "end": 1184,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                }
            ],
            "section": "Epidemiology",
            "ref_spans": []
        },
        {
            "text": "AdV accounts for at least 5 to 10% of pediatric and 1 to 7% of adult respiratory tract infections (RTIs).2\n31 Typical symptoms of AdV RTI include fever, pharyngitis, tonsillitis, cough, and sore throat.3\n19 GI symptoms may be present concomitantly, particularly in children.3\n13\n19\n88 In immunocompetent patients, symptoms usually abate spontaneously (within 2 weeks) and infection induces type-specific immunity.2 Pneumonia occurs in up to 20% of newborns and infants,3\n10\n12\n88\n89 but is uncommon in immunocompetent adults.2\n16\n17\n77\n79\n90\n91 However, fatalities due to AdV pneumonia have been described in previously healthy children10 or adults.19\n23\n65\n79\n90 In immunocompromised persons, dissemination and/or severe respiratory failure develop in 10 to 30% of cases2\n9\n27\n38 and fatality rates for severe AdV pneumonia may exceed 50%2\n9\n90 (Fig. 1).",
            "cite_spans": [
                {
                    "start": 105,
                    "end": 106,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 107,
                    "end": 109,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 202,
                    "end": 203,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 204,
                    "end": 206,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 274,
                    "end": 275,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 276,
                    "end": 278,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 279,
                    "end": 281,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 282,
                    "end": 284,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 413,
                    "end": 414,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 469,
                    "end": 470,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 471,
                    "end": 473,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 474,
                    "end": 476,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 477,
                    "end": 479,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 480,
                    "end": 482,
                    "mention": "89",
                    "ref_id": "BIBREF314"
                },
                {
                    "start": 525,
                    "end": 526,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 527,
                    "end": 529,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 530,
                    "end": 532,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 533,
                    "end": 535,
                    "mention": "77",
                    "ref_id": "BIBREF301"
                },
                {
                    "start": 536,
                    "end": 538,
                    "mention": "79",
                    "ref_id": "BIBREF303"
                },
                {
                    "start": 539,
                    "end": 541,
                    "mention": "90",
                    "ref_id": "BIBREF316"
                },
                {
                    "start": 542,
                    "end": 544,
                    "mention": "91",
                    "ref_id": "BIBREF317"
                },
                {
                    "start": 636,
                    "end": 638,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 649,
                    "end": 651,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 652,
                    "end": 654,
                    "mention": "23",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "65",
                    "ref_id": "BIBREF288"
                },
                {
                    "start": 658,
                    "end": 660,
                    "mention": "79",
                    "ref_id": "BIBREF303"
                },
                {
                    "start": 661,
                    "end": 663,
                    "mention": "90",
                    "ref_id": "BIBREF316"
                },
                {
                    "start": 771,
                    "end": 772,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 773,
                    "end": 774,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 775,
                    "end": 777,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 778,
                    "end": 780,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 839,
                    "end": 840,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 841,
                    "end": 842,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 843,
                    "end": 845,
                    "mention": "90",
                    "ref_id": "BIBREF316"
                }
            ],
            "section": "Respiratory Tract Involvement ::: Clinical Features of Adenovirus Infection",
            "ref_spans": [
                {
                    "start": 847,
                    "end": 853,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "In children, long-term respiratory sequela of AdV RTI include bronchiectasis, bronchiolitis obliterans, and hyperlucent lung.92\n93\n94 AdVs have a propensity to establish latent or persistent infection within the upper95 and lower respiratory tracts.96 Persistent AdV infection in children may elicit chronic neutrophilic inflammation within the airways, protracted bacterial bronchitis and bronchiectasis.97\n98\n99 HAdVs (particularly types 1\u20135, 7, 14, and 21) have been associated with small airways dysfunction96 and bronchiectasis in children94\n98 and chronic obstructive pulmonary disease in adults.100\n101 These various studies suggest that HAdV is not an innocent bystander in the lower airways, but may play a role in the pathogenesis of chronic suppurative endobronchial and lung disease.",
            "cite_spans": [
                {
                    "start": 125,
                    "end": 127,
                    "mention": "92",
                    "ref_id": "BIBREF318"
                },
                {
                    "start": 128,
                    "end": 130,
                    "mention": "93",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 131,
                    "end": 133,
                    "mention": "94",
                    "ref_id": "BIBREF319"
                },
                {
                    "start": 217,
                    "end": 219,
                    "mention": "95",
                    "ref_id": "BIBREF320"
                },
                {
                    "start": 249,
                    "end": 251,
                    "mention": "96",
                    "ref_id": "BIBREF321"
                },
                {
                    "start": 405,
                    "end": 407,
                    "mention": "97",
                    "ref_id": "BIBREF322"
                },
                {
                    "start": 408,
                    "end": 410,
                    "mention": "98",
                    "ref_id": "BIBREF323"
                },
                {
                    "start": 411,
                    "end": 413,
                    "mention": "99",
                    "ref_id": "BIBREF324"
                },
                {
                    "start": 511,
                    "end": 513,
                    "mention": "96",
                    "ref_id": "BIBREF321"
                },
                {
                    "start": 544,
                    "end": 546,
                    "mention": "94",
                    "ref_id": "BIBREF319"
                },
                {
                    "start": 547,
                    "end": 549,
                    "mention": "98",
                    "ref_id": "BIBREF323"
                },
                {
                    "start": 602,
                    "end": 605,
                    "mention": "100",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 606,
                    "end": 609,
                    "mention": "101",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Respiratory Tract Involvement ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "Manifestations of ocular AdV infection include: epidemic KC (EKC), pharyngoconjunctival fever, and nonspecific conjunctivitis.49\n102\n103\n104\n105\n106 The most common serotypes associated with EKC are AdV-8, -19, and -37,49\n103\n105\n106\n107\n108\n109\n110\n111\n112 but other serotypes (e.g., AdV-3, -4, -7, -11, and -14) can also cause conjunctivitis.46\n47\n105\n106\n108\n113\n114 Outbreaks of EKC can occur in hospitals or outpatient clinics,102\n103\n115 chronic care facilities,66\n116 and closed settings.117 Nosocomial transmission has been noted in eye clinics or hospitals via environmental contamination (ophthalmic instruments, eyedrops).103\n115\n118 Rigorous sterilization of instruments and strict infection control were essential to curb epidemics.103\n115 The recently described genotypes 53, 54, and 56 of species HAdV-D have been reported in association with outbreaks of EKC.119\n120\n121\n122\n123\n124\n",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 128,
                    "mention": "49",
                    "ref_id": "BIBREF270"
                },
                {
                    "start": 129,
                    "end": 132,
                    "mention": "102",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 133,
                    "end": 136,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 137,
                    "end": 140,
                    "mention": "104",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 141,
                    "end": 144,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 145,
                    "end": 148,
                    "mention": "106",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 219,
                    "end": 221,
                    "mention": "49",
                    "ref_id": "BIBREF270"
                },
                {
                    "start": 222,
                    "end": 225,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 226,
                    "end": 229,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 230,
                    "end": 233,
                    "mention": "106",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 234,
                    "end": 237,
                    "mention": "107",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 238,
                    "end": 241,
                    "mention": "108",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 242,
                    "end": 245,
                    "mention": "109",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 246,
                    "end": 249,
                    "mention": "110",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 250,
                    "end": 253,
                    "mention": "111",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 254,
                    "end": 257,
                    "mention": "112",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 344,
                    "end": 346,
                    "mention": "46",
                    "ref_id": "BIBREF267"
                },
                {
                    "start": 347,
                    "end": 349,
                    "mention": "47",
                    "ref_id": "BIBREF268"
                },
                {
                    "start": 350,
                    "end": 353,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 354,
                    "end": 357,
                    "mention": "106",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 358,
                    "end": 361,
                    "mention": "108",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 362,
                    "end": 365,
                    "mention": "113",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 366,
                    "end": 369,
                    "mention": "114",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 432,
                    "end": 435,
                    "mention": "102",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 436,
                    "end": 439,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 440,
                    "end": 443,
                    "mention": "115",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 468,
                    "end": 470,
                    "mention": "66",
                    "ref_id": "BIBREF289"
                },
                {
                    "start": 471,
                    "end": 474,
                    "mention": "116",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 495,
                    "end": 498,
                    "mention": "117",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 633,
                    "end": 636,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 637,
                    "end": 640,
                    "mention": "115",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 641,
                    "end": 644,
                    "mention": "118",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 745,
                    "end": 748,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 749,
                    "end": 752,
                    "mention": "115",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 875,
                    "end": 878,
                    "mention": "119",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 879,
                    "end": 882,
                    "mention": "120",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 883,
                    "end": 886,
                    "mention": "121",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 887,
                    "end": 890,
                    "mention": "122",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 891,
                    "end": 894,
                    "mention": "123",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 895,
                    "end": 898,
                    "mention": "124",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Keratoconjunctivitis ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "AdV infections can cause GI symptoms even when the primary site of involvement is the respiratory tract (particularly in young children).3\n13\n88\n125 Some serotypes (notably AdV-40 and -41) have an affinity for the GI tract,50\n53\n54\n57 with predominant symptoms of gastroenteritis or diarrhea.126 Rare complications include hemorrhagic colitis,2\n27\n127 hepatitis,27\n128\n129\n130\n131 cholecystitis,132 and pancreatitis.133\n134\n",
            "cite_spans": [
                {
                    "start": 137,
                    "end": 138,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 139,
                    "end": 141,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 142,
                    "end": 144,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 145,
                    "end": 148,
                    "mention": "125",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 223,
                    "end": 225,
                    "mention": "50",
                    "ref_id": "BIBREF272"
                },
                {
                    "start": 226,
                    "end": 228,
                    "mention": "53",
                    "ref_id": "BIBREF275"
                },
                {
                    "start": 229,
                    "end": 231,
                    "mention": "54",
                    "ref_id": "BIBREF276"
                },
                {
                    "start": 232,
                    "end": 234,
                    "mention": "57",
                    "ref_id": "BIBREF279"
                },
                {
                    "start": 292,
                    "end": 295,
                    "mention": "126",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 343,
                    "end": 344,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 345,
                    "end": 347,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 348,
                    "end": 351,
                    "mention": "127",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 362,
                    "end": 364,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 365,
                    "end": 368,
                    "mention": "128",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 369,
                    "end": 372,
                    "mention": "129",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 373,
                    "end": 376,
                    "mention": "130",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 377,
                    "end": 380,
                    "mention": "131",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 395,
                    "end": 398,
                    "mention": "132",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 416,
                    "end": 419,
                    "mention": "133",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 420,
                    "end": 423,
                    "mention": "134",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Gastrointestinal Manifestations ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "AdV may cause urinary tract infections (UTIs),135 particularly among hematopoietic stem cell transplant (HSCT)71\n136\n137\n138\n139 and solid organ transplant (SOT) recipients.140\n141\n142\n143 Typical manifestations include dysuria, hematuria, hemorrhagic cystitis (HC), and renal allograft dysfunction.141\n142\n144\n145 Most AdV UTIs (including HC) are self-limiting43\n71\n140\n144 but fatal or dialysis-dependent renal failure,146\n147\n148 fatal dissemination,149\n150 necrotizing tubulointerstitial nephritis,148\n151 or obstructive uropathy151 have been described. Most common serotypes associated with HC include: AdV-11, -34, -35, -3, -7, and -21.2\n142\n144\n148 The diagnosis may be confirmed by culture or polymerase chain reaction (PCR) in urine, or serology.2\n137\n142 Renal biopsy may demonstrate viral infection of tubular epithelial cells, with \u201csmudge cells\u201d and intranuclear inclusions.147\n148 AdV urethritis has also been described.152\n",
            "cite_spans": [
                {
                    "start": 46,
                    "end": 49,
                    "mention": "135",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 110,
                    "end": 112,
                    "mention": "71",
                    "ref_id": "BIBREF295"
                },
                {
                    "start": 113,
                    "end": 116,
                    "mention": "136",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 117,
                    "end": 120,
                    "mention": "137",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 121,
                    "end": 124,
                    "mention": "138",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 125,
                    "end": 128,
                    "mention": "139",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 173,
                    "end": 176,
                    "mention": "140",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 177,
                    "end": 180,
                    "mention": "141",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 181,
                    "end": 184,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 185,
                    "end": 188,
                    "mention": "143",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 299,
                    "end": 302,
                    "mention": "141",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 303,
                    "end": 306,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 307,
                    "end": 310,
                    "mention": "144",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 311,
                    "end": 314,
                    "mention": "145",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 361,
                    "end": 363,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 364,
                    "end": 366,
                    "mention": "71",
                    "ref_id": "BIBREF295"
                },
                {
                    "start": 367,
                    "end": 370,
                    "mention": "140",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 371,
                    "end": 374,
                    "mention": "144",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 421,
                    "end": 424,
                    "mention": "146",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 425,
                    "end": 428,
                    "mention": "147",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 429,
                    "end": 432,
                    "mention": "148",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 453,
                    "end": 456,
                    "mention": "149",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 457,
                    "end": 460,
                    "mention": "150",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 502,
                    "end": 505,
                    "mention": "148",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 506,
                    "end": 509,
                    "mention": "151",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 533,
                    "end": 536,
                    "mention": "151",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 642,
                    "end": 643,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 644,
                    "end": 647,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 648,
                    "end": 651,
                    "mention": "144",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 652,
                    "end": 655,
                    "mention": "148",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 755,
                    "end": 756,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 757,
                    "end": 760,
                    "mention": "137",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 761,
                    "end": 764,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 887,
                    "end": 890,
                    "mention": "147",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 891,
                    "end": 894,
                    "mention": "148",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 934,
                    "end": 937,
                    "mention": "152",
                    "ref_id": "BIBREF62"
                }
            ],
            "section": "Urinary Tract Involvement ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "Disseminated AdV infections are rare among immunocompetent hosts, but dissemination occurs in 10 to 30% of HSCT recipients with AdV infection.2\n25\n26\n38\n153\n154\n155 Diagnosis is made by PCR in blood150 and/or detection (or recovery) of AdV from more than one site. Among HSCT recipients with symptomatic AdV disease, fatality rates range from 12 to 70%.25\n153\n156\n157\n158 Case fatality rates for AdV pneumonia may exceed 50%.27\n90\n",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 143,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 144,
                    "end": 146,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 147,
                    "end": 149,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 150,
                    "end": 152,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 153,
                    "end": 156,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 157,
                    "end": 160,
                    "mention": "154",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 161,
                    "end": 164,
                    "mention": "155",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 198,
                    "end": 201,
                    "mention": "150",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 353,
                    "end": 355,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 356,
                    "end": 359,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 360,
                    "end": 363,
                    "mention": "156",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 364,
                    "end": 367,
                    "mention": "157",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 368,
                    "end": 371,
                    "mention": "158",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 425,
                    "end": 427,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 428,
                    "end": 430,
                    "mention": "90",
                    "ref_id": "BIBREF316"
                }
            ],
            "section": "Disseminated Disease ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "Rare manifestations of AdV infections include: encephalitis159\n160\n161\n162\n163; meningitis162\n164\n165; myocarditis and cardiomyopathy166\n167;mononucleosis-like syndromes168; pulmonary dysplasia169; intestinal intussusception in children170; sudden infant death.171\n",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 62,
                    "mention": "159",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 63,
                    "end": 66,
                    "mention": "160",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 67,
                    "end": 70,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 71,
                    "end": 74,
                    "mention": "162",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 75,
                    "end": 78,
                    "mention": "163",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 90,
                    "end": 93,
                    "mention": "162",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 94,
                    "end": 97,
                    "mention": "164",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 98,
                    "end": 101,
                    "mention": "165",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 133,
                    "end": 136,
                    "mention": "166",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 137,
                    "end": 140,
                    "mention": "167",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 169,
                    "end": 172,
                    "mention": "168",
                    "ref_id": "BIBREF79"
                },
                {
                    "start": 193,
                    "end": 196,
                    "mention": "169",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 236,
                    "end": 239,
                    "mention": "170",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 261,
                    "end": 264,
                    "mention": "171",
                    "ref_id": "BIBREF83"
                }
            ],
            "section": "Rare Manifestations ::: Clinical Features of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "Epidemics of AdV respiratory infection may occur in healthy children (particularly < 4 years old)3\n10\n11\n12\n13\n172 or adults in closed settings (particularly the military).17\n19\n20\n21\n173 The vast majority of cases are self-limited; disseminated and fatal infections are rare in immunocompetent hosts.19\n90\n",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 98,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 99,
                    "end": 101,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 102,
                    "end": 104,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 105,
                    "end": 107,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 108,
                    "end": 110,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 111,
                    "end": 114,
                    "mention": "172",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 172,
                    "end": 174,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 175,
                    "end": 177,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 178,
                    "end": 180,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 181,
                    "end": 183,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 184,
                    "end": 187,
                    "mention": "173",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 301,
                    "end": 303,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 304,
                    "end": 306,
                    "mention": "90",
                    "ref_id": "BIBREF316"
                }
            ],
            "section": "Adenovirus Infections in Immunocompetent Persons ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "AdV accounts for > 50% of FRI and pneumonia cases among unvaccinated military recruits,16\n17\n20\n33\n68\n69\n173 not only in the United States19\n40\n74 but globally.44\n75 Military recruits are especially vulnerable during basic training, owing to crowding and stresses.19 In a survey of eight military training sites in the United States from 2004 to 2009, > 21,000 cases of FRI or pneumonia were detected; AdV was implicated in 63.6%; influenza, in only 6.6%.76 Peak illness rates occur during weeks 3 to 5 of training.20 In a prospective study of 271 new military recruits in training, 25% developed an acute FRI due to AdV-4 over a 6-week period; all FRIs occurred among recruits with an initial AdV antibody titer of < 1:4.69 Serum antibodies to AdV-4 were present in 34% at enrollment, and 97% by 6 weeks.69 Following completion of basic training, recruits are dispersed to secondary sites, paving the way for epidemic spread.86 Historically, serotypes AdV-7 and -4 predominated as a cause of FRIs in the military in the United States.16\n17\n40 Beginning in 1971, all recruits in the United States military were vaccinated with live enteric-coated AdV-4 and -7 vaccines.174 Following this strategy, the incidence of AdV infections in the military setting plummeted.174 In 1995, the sole manufacturer of the AdV vaccines ceased production; existing supplies were completely depleted by 1999.19 In 1996, the last year AdV vaccines were given to recruits year round, AdV-21 was the most prevalent type, implicated in 58% of AdV infections; AdV-4 and -7 were each implicated in only 4%.175 The lack of availability of vaccines led to re-emergence of epidemics of AdV infections in military facilities in the United States.19\n20\n40\n74\n176\n177\n178 Surveillance of U. S. recruits in training cited > 73,000 AdV infections from 1999 to 2004; serotype 4 accounted for > 95% of AdV infections.20 In a large surveillance study of eight military recruit training centers in the United States from 2000 to 2011, AdV-4 was implicated in 80% of AdV infections; the remaining 20% comprised AdV-14, -21, -3, and -7.175 In 2006 and 2007, a novel strain of AdV-14 emerged as a cause of FRIs in recruits at a U. S. Air Force base,33 and became the predominant strain in the military.",
            "cite_spans": [
                {
                    "start": 87,
                    "end": 89,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 90,
                    "end": 92,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 93,
                    "end": 95,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 96,
                    "end": 98,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 99,
                    "end": 101,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 102,
                    "end": 104,
                    "mention": "69",
                    "ref_id": "BIBREF292"
                },
                {
                    "start": 105,
                    "end": 108,
                    "mention": "173",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 138,
                    "end": 140,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 141,
                    "end": 143,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 144,
                    "end": 146,
                    "mention": "74",
                    "ref_id": "BIBREF298"
                },
                {
                    "start": 160,
                    "end": 162,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 163,
                    "end": 165,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 264,
                    "end": 266,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 455,
                    "end": 457,
                    "mention": "76",
                    "ref_id": "BIBREF300"
                },
                {
                    "start": 515,
                    "end": 517,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 722,
                    "end": 724,
                    "mention": "69",
                    "ref_id": "BIBREF292"
                },
                {
                    "start": 805,
                    "end": 807,
                    "mention": "69",
                    "ref_id": "BIBREF292"
                },
                {
                    "start": 926,
                    "end": 928,
                    "mention": "86",
                    "ref_id": "BIBREF311"
                },
                {
                    "start": 1035,
                    "end": 1037,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 1038,
                    "end": 1040,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 1041,
                    "end": 1043,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 1169,
                    "end": 1172,
                    "mention": "174",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1264,
                    "end": 1267,
                    "mention": "174",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1389,
                    "end": 1391,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1581,
                    "end": 1584,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 1717,
                    "end": 1719,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 1720,
                    "end": 1722,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 1723,
                    "end": 1725,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 1726,
                    "end": 1728,
                    "mention": "74",
                    "ref_id": "BIBREF298"
                },
                {
                    "start": 1729,
                    "end": 1732,
                    "mention": "176",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 1733,
                    "end": 1736,
                    "mention": "177",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1737,
                    "end": 1740,
                    "mention": "178",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 1882,
                    "end": 1884,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 2097,
                    "end": 2100,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 2209,
                    "end": 2211,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                }
            ],
            "section": "Adenovirus Infections in Military Recruits ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "Beginning in October 2011, after a 12-year hiatus, the administration of live nonattenuated oral vaccines against AdV-4 and -7 to U. S. military recruits was resumed.179 From 1996 to 2013, FRI surveillance was performed at eight military training centers in the United States.175 During the 2 years after reintroduction of the vaccine, AdV burden declined 100-fold (from 5.8 to 0.02 cases per 1,000 person weeks, p < 0.001).175 Although the percentage of type 14 increased following reintroduction of the vaccine, the mean annual number of AdV-14 infections decreased (from 610 in 2000 to 2011 to 44 in 2013).175 Continuing to vaccinate all incoming recruits will reduce cases among trainees, and may reduce transmission to other geographical locations and to civilians.175 Future surveillance studies will monitor AdV infection rates and pay attention to emergence of AdV types not targeted by the vaccines.",
            "cite_spans": [
                {
                    "start": 166,
                    "end": 169,
                    "mention": "179",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 276,
                    "end": 279,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 424,
                    "end": 427,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 609,
                    "end": 612,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 770,
                    "end": 773,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                }
            ],
            "section": "Adenovirus Infections in Military Recruits ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "The incidence of AdV infections among HSCT recipients is highly variable (range, 3\u201347%).2\n4\n25\n26\n27\n28\n42\n153\n154\n155\n156\n180\n181\n182\n183\n184 The incidence is much higher among allogeneic (range, 5\u201347%)4 compared with autologous (range, 2.5\u201314%)185\n186\n187 HSCT recipients. Higher rates of AdV infections reflect prospective studies with regular (often weekly) sampling of plasma for AdV DNA (by PCR).153\n188 The incidence is 2 to 3.5 times higher in children (> 20%) compared with < 10% in adults.38\n181\n182\n189\n190 Additional risk factors for AdV infections among HSCT recipients include: allogeneic HSCT4\n38\n182; graft versus host disease (GVHD)2\n25\n27\n28\n153\n154\n156\n182\n191; severe T-cell depletion28\n38\n191; human leukocyte antigen (HLA) mismatch.38\n192 Infection can reflect primary infection (e.g., community or nosocomial acquisition)73 or reactivation of latent infection.70\n73\n",
            "cite_spans": [
                {
                    "start": 88,
                    "end": 89,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 90,
                    "end": 91,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 92,
                    "end": 94,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 95,
                    "end": 97,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 98,
                    "end": 100,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 101,
                    "end": 103,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 104,
                    "end": 106,
                    "mention": "42",
                    "ref_id": "BIBREF263"
                },
                {
                    "start": 107,
                    "end": 110,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 111,
                    "end": 114,
                    "mention": "154",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 115,
                    "end": 118,
                    "mention": "155",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 119,
                    "end": 122,
                    "mention": "156",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 123,
                    "end": 126,
                    "mention": "180",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 127,
                    "end": 130,
                    "mention": "181",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 131,
                    "end": 134,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 135,
                    "end": 138,
                    "mention": "183",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 139,
                    "end": 142,
                    "mention": "184",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 203,
                    "end": 204,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 246,
                    "end": 249,
                    "mention": "185",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 250,
                    "end": 253,
                    "mention": "186",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 254,
                    "end": 257,
                    "mention": "187",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 402,
                    "end": 405,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 406,
                    "end": 409,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 499,
                    "end": 501,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 502,
                    "end": 505,
                    "mention": "181",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 506,
                    "end": 509,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 510,
                    "end": 513,
                    "mention": "189",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 514,
                    "end": 517,
                    "mention": "190",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 607,
                    "end": 608,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 609,
                    "end": 611,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 612,
                    "end": 615,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 649,
                    "end": 650,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 651,
                    "end": 653,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 654,
                    "end": 656,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 657,
                    "end": 659,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 660,
                    "end": 663,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 664,
                    "end": 667,
                    "mention": "154",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 668,
                    "end": 671,
                    "mention": "156",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 672,
                    "end": 675,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 676,
                    "end": 679,
                    "mention": "191",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 704,
                    "end": 706,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 707,
                    "end": 709,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 710,
                    "end": 713,
                    "mention": "191",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 754,
                    "end": 756,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 757,
                    "end": 760,
                    "mention": "192",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 844,
                    "end": 846,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                },
                {
                    "start": 883,
                    "end": 885,
                    "mention": "70",
                    "ref_id": "BIBREF294"
                },
                {
                    "start": 886,
                    "end": 888,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                }
            ],
            "section": "Hematopoietic Stem Cell Transplant Recipients ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "AdV in HSCT recipients is usually detected within 100 days of transplant.38\n193 The disease is usually localized (e.g., urinary tract, gastroenteritis, upper or lower respiratory tract) but dissemination occurs in 10 to 30% of cases.28\n38\n181\n189 In this context, mortality rates are high.38 Among 76 adult HSCT recipients with symptomatic AdV infections, mortality rate was 26%.182 Mortality rates were higher among patients with pneumonia (73%) and disseminated disease (61%).182 Severe lymphopenia,2\n38 severe GVHD,28\n182 isolation from more than one site,38 and high AdV viral loads in plasma194\n195 correlate with higher mortality. In one study of 123 consecutive pediatric allogeneic HSCT recipients, 12.3% developed symptomatic AdV infections.183 Overall survival was much worse in patients with AdV infections (15.4%) compared with noninfected subjects (50%; p < 0.03). In multivariate analysis, the most important risk factor for mortality was AdV infection (hazard ratio, 3.15; p < 0.001).183 However, prognosis may be good, particularly when the viral load is low. A retrospective study in pediatric HSCT recipients detected AdV in blood (by PCR) in 11/26 (42%); viremia cleared in 7 (63%) without antiviral therapy.43 In another study of 116 adult HSCT recipients who had weekly screening for AdV in blood by PCR, 14 (12.1%) developed AdV viremia.193 Only five were treated with cidofovir (CDV); only one died as a result of AdV infection. In another study of pediatric HSCT recipients, weekly sampling of plasma PCR identified 57 patients with AdV infections; 8 (14%) patients had disseminated disease. All 57 patients were treated with intravenous CDV; clinical and microbiological cure was achieved in 56 (98%). One patient died of AdV pneumonia.188 Quantification of AdV DNA load by real-time PCR in plasma of HSCT recipients may identify patients at high risk for dissemination189\n194 or assess response to therapy.189\n194 However, indications for, and duration of therapy, with CDV are controversial.",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 75,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 76,
                    "end": 79,
                    "mention": "193",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 233,
                    "end": 235,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 236,
                    "end": 238,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 239,
                    "end": 242,
                    "mention": "181",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 243,
                    "end": 246,
                    "mention": "189",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 289,
                    "end": 291,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 379,
                    "end": 382,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 478,
                    "end": 481,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 501,
                    "end": 502,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 503,
                    "end": 505,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 518,
                    "end": 520,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 521,
                    "end": 524,
                    "mention": "182",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 559,
                    "end": 561,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 596,
                    "end": 599,
                    "mention": "194",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 600,
                    "end": 603,
                    "mention": "195",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 750,
                    "end": 753,
                    "mention": "183",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 999,
                    "end": 1002,
                    "mention": "183",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 1227,
                    "end": 1229,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 1359,
                    "end": 1362,
                    "mention": "193",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 1761,
                    "end": 1764,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 1894,
                    "end": 1897,
                    "mention": "189",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1898,
                    "end": 1901,
                    "mention": "194",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 1932,
                    "end": 1935,
                    "mention": "189",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1936,
                    "end": 1939,
                    "mention": "194",
                    "ref_id": "BIBREF108"
                }
            ],
            "section": "Hematopoietic Stem Cell Transplant Recipients ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "The incidence of AdV infections among SOT recipients is 5 to 22%, usually within the first 6 months posttransplantation.2\n4\n38\n156\n196\n197 AdV infections have been noted in liver,198\n199 renal,140\n142\n146\n200\n201\n202 heart,196\n203\n204 intestinal,205\n206 and lung207\n208\n209 transplant recipients. Among SOT recipients, risk factors for AdV include: pediatric age4\n38\n198; donor-positive/recipient-negative AdV status38; receipt of antilymphocyte antibodies.38 In a prospective study, AdV viremia (by PCR) was detected within 12 months of transplant in 19/263 (7.3%) SOT recipients including: liver, 10/121 (8.3%); kidney, 6/92 (6.5%); heart, 3/45 (6.7%).196 At the time of viremia, 11 (58%) were asymptomatic. All recovered spontaneously without sequela. In a retrospective review of 484 pediatric liver transplant recipients, 49 (10%) developed AdV infections; 9 died of invasive AdV infection.198 In another retrospective review of 191 adult liver transplant recipients, 11 (5.8%) had AdV infection, and 2 AdV-associated deaths were documented.199 Clinical manifestations of AdV infection are protean, but the primary site of disease in SOT recipients is often related to the transplanted organ.38\n210 In liver transplant recipients, AdV typically causes hepatitis, jaundice, and hepatomegaly.38 In renal transplant patients, HC is the principal symptom; further, AdV may target the renal allograft, leading to graft failure.142\n146\n200 In pediatric heart transplant recipients, the presence of AdV in posttransplant endomyocardial biopsies increased the risk for graft loss and posttransplant coronary artery disease.211\n212\n213 In a cohort of 383 lung transplant recipients (LTRs), only 4 AdV infections were identified; incidence was 3/40 (8%) among pediatric LTR and 1/268 (0.4%) among adult LTR.207 However, all four developed severe hemorrhagic, necrotizing AdV pneumonia; all died within 45 days of transplant. In another study of 19 pediatric LTR, 8 developed AdV, resulting in 2 early deaths, as well as late graft loss and obliterative bronchiolitis.200 A case of fatal AdV pneumonia in an adult LTR 4 years posttransplant was described.214 Although AdV can cause fatal infections in SOT recipients, indications for treatment with CDV for mild infections have not been established. AdV viremia may be asymptomatic, and may clear spontaneously.196 Routine PCR surveillance is not recommended in adult SOT recipients. Further, treatment (with CDV) should be reserved for symptomatic patients or those with pneumonia or disseminated infection.",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 121,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 122,
                    "end": 123,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 124,
                    "end": 126,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 127,
                    "end": 130,
                    "mention": "156",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 131,
                    "end": 134,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 135,
                    "end": 138,
                    "mention": "197",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 179,
                    "end": 182,
                    "mention": "198",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 183,
                    "end": 186,
                    "mention": "199",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 193,
                    "end": 196,
                    "mention": "140",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 197,
                    "end": 200,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 201,
                    "end": 204,
                    "mention": "146",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 205,
                    "end": 208,
                    "mention": "200",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 209,
                    "end": 212,
                    "mention": "201",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 213,
                    "end": 216,
                    "mention": "202",
                    "ref_id": "BIBREF118"
                },
                {
                    "start": 223,
                    "end": 226,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 227,
                    "end": 230,
                    "mention": "203",
                    "ref_id": "BIBREF119"
                },
                {
                    "start": 231,
                    "end": 234,
                    "mention": "204",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 246,
                    "end": 249,
                    "mention": "205",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 250,
                    "end": 253,
                    "mention": "206",
                    "ref_id": "BIBREF122"
                },
                {
                    "start": 262,
                    "end": 265,
                    "mention": "207",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 266,
                    "end": 269,
                    "mention": "208",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 270,
                    "end": 273,
                    "mention": "209",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 362,
                    "end": 363,
                    "mention": "4",
                    "ref_id": "BIBREF260"
                },
                {
                    "start": 364,
                    "end": 366,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 367,
                    "end": 370,
                    "mention": "198",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 416,
                    "end": 418,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 457,
                    "end": 459,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 654,
                    "end": 657,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 895,
                    "end": 898,
                    "mention": "198",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 1046,
                    "end": 1049,
                    "mention": "199",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 1197,
                    "end": 1199,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 1200,
                    "end": 1203,
                    "mention": "210",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 1295,
                    "end": 1297,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 1427,
                    "end": 1430,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 1431,
                    "end": 1434,
                    "mention": "146",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 1435,
                    "end": 1438,
                    "mention": "200",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 1620,
                    "end": 1623,
                    "mention": "211",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 1624,
                    "end": 1627,
                    "mention": "212",
                    "ref_id": "BIBREF129"
                },
                {
                    "start": 1628,
                    "end": 1631,
                    "mention": "213",
                    "ref_id": "BIBREF130"
                },
                {
                    "start": 1802,
                    "end": 1805,
                    "mention": "207",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 2062,
                    "end": 2065,
                    "mention": "200",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 2149,
                    "end": 2152,
                    "mention": "214",
                    "ref_id": "BIBREF131"
                },
                {
                    "start": 2355,
                    "end": 2358,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                }
            ],
            "section": "Solid Organ Transplant Recipients ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "AdV infections occur in 12 to 28% of human immunodeficiency virus (HIV)-infected patients.215\n216 In one prospective study of 63 HIV+ patients, 18 (28%) developed AdV infections within 1 year (17% if CD4 count was > 200/mm3 vs. 38% if the CD4 count was < 200/mm3).216 In Nigeria, 39% of 184 HIV-infected patients had serological evidence for AdV infection.217 The GI tract is involved in > 90%, but most patients are asymptomatic or have mild symptoms (e.g., diarrhea).216 UTIs occur in up to 20% of AIDS patients,218 but HC is rare.38 Serotype D is associated with GI infection whereas UTIs are usually caused by serotypes B or D.216 AdV (particularly serotypes 1 to 3) may cause fatal cases in HIV-infected patients.38\n197 Since the availability of highly active antiretroviral therapy, AdV disease is uncommon in HIV/AIDS patients until immune system deterioration occurs.38\n",
            "cite_spans": [
                {
                    "start": 90,
                    "end": 93,
                    "mention": "215",
                    "ref_id": "BIBREF132"
                },
                {
                    "start": 94,
                    "end": 97,
                    "mention": "216",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 264,
                    "end": 267,
                    "mention": "216",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 356,
                    "end": 359,
                    "mention": "217",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 469,
                    "end": 472,
                    "mention": "216",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 514,
                    "end": 517,
                    "mention": "218",
                    "ref_id": "BIBREF135"
                },
                {
                    "start": 533,
                    "end": 535,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 631,
                    "end": 634,
                    "mention": "216",
                    "ref_id": "BIBREF133"
                },
                {
                    "start": 718,
                    "end": 720,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 721,
                    "end": 724,
                    "mention": "197",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 875,
                    "end": 877,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                }
            ],
            "section": "Human Immunodeficiency Virus Infection ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "AdV infection may complicate congenital immunodeficiency disorders such as severe combined immunodeficiency syndrome, common variable immunodeficiency, agammaglobulinemia, immunoglobulin A deficiency, and others.38\n64\n197\n219 In patients with severe immunodeficiency, AdV tends to cause severe and recurrent pulmonary infections, disseminated disease, and even death.38\n",
            "cite_spans": [
                {
                    "start": 212,
                    "end": 214,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 215,
                    "end": 217,
                    "mention": "64",
                    "ref_id": "BIBREF287"
                },
                {
                    "start": 218,
                    "end": 221,
                    "mention": "197",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 222,
                    "end": 225,
                    "mention": "219",
                    "ref_id": "BIBREF136"
                },
                {
                    "start": 367,
                    "end": 369,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                }
            ],
            "section": "Congenital Immunodeficiency Syndromes ::: Specific Patient Populations at Risk",
            "ref_spans": []
        },
        {
            "text": "Globally, serotypes 1 to 5, 7, 21, and 41 are most commonly associated with human disease (Table 1). Different serotypes display different tissue tropisms and clinical manifestations of infection.2\n26\n31\n33 Among children, the most common AdV serotypes associated with RTI are types 1 to 7 and an intertypic recombinant H11F14 designated as genotype 55.31\n220 In adults, serotypes most often implicated in FRI include: AdV-1 to 7, -21, and -14.10\n16\n17\n18\n24\n33\n40\n41\n75\n221\n222 AdV-55 was implicated in outbreaks of FRI in China,81 Singapore,44 the Middle East,223 United States,21 and South America.224 AdV-11 may cause UTIs or HC in children or transplant recipients.33\n38 Other serotypes associated with HC include: AdV-7, -33, -34, and -35.33\n225 AdV-8, -19, and -37 are frequent causative agents of KC.31\n105\n226 Gastroenteritis is most frequently associated with infection by enteric AdV-40 and -41,9\n227 but has also been reported in association with AdV-12, -18, and -31,9 and AdV-5232 infection. AdV-5, -31, -34, -35, and -39 have been implicated in infections in immunocompromised patients43\n51\n180\n220\n228 (particularly HSCT2\n43\n128\n229\n230 or SOT142\n231 recipients). Hepatitis has been reported associated with infection by serotypes 1 to 3, 5, and 7.38\n225\n",
            "cite_spans": [
                {
                    "start": 196,
                    "end": 197,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 198,
                    "end": 200,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 201,
                    "end": 203,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 204,
                    "end": 206,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 353,
                    "end": 355,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 356,
                    "end": 359,
                    "mention": "220",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 444,
                    "end": 446,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 447,
                    "end": 449,
                    "mention": "16",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 450,
                    "end": 452,
                    "mention": "17",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 453,
                    "end": 455,
                    "mention": "18",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 456,
                    "end": 458,
                    "mention": "24",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 459,
                    "end": 461,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 462,
                    "end": 464,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 465,
                    "end": 467,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                },
                {
                    "start": 468,
                    "end": 470,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 471,
                    "end": 474,
                    "mention": "221",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 475,
                    "end": 478,
                    "mention": "222",
                    "ref_id": "BIBREF139"
                },
                {
                    "start": 530,
                    "end": 532,
                    "mention": "81",
                    "ref_id": "BIBREF306"
                },
                {
                    "start": 543,
                    "end": 545,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 562,
                    "end": 565,
                    "mention": "223",
                    "ref_id": "BIBREF140"
                },
                {
                    "start": 580,
                    "end": 582,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 601,
                    "end": 604,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 670,
                    "end": 672,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 673,
                    "end": 675,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 745,
                    "end": 747,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 748,
                    "end": 751,
                    "mention": "225",
                    "ref_id": "BIBREF142"
                },
                {
                    "start": 808,
                    "end": 810,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 811,
                    "end": 814,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 815,
                    "end": 818,
                    "mention": "226",
                    "ref_id": "BIBREF143"
                },
                {
                    "start": 906,
                    "end": 907,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 908,
                    "end": 911,
                    "mention": "227",
                    "ref_id": "BIBREF144"
                },
                {
                    "start": 980,
                    "end": 981,
                    "mention": "9",
                    "ref_id": "BIBREF315"
                },
                {
                    "start": 992,
                    "end": 994,
                    "mention": "32",
                    "ref_id": "BIBREF246"
                },
                {
                    "start": 1100,
                    "end": 1102,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 1103,
                    "end": 1105,
                    "mention": "51",
                    "ref_id": "BIBREF273"
                },
                {
                    "start": 1106,
                    "end": 1109,
                    "mention": "180",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 1110,
                    "end": 1113,
                    "mention": "220",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1114,
                    "end": 1117,
                    "mention": "228",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1136,
                    "end": 1137,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1138,
                    "end": 1140,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 1141,
                    "end": 1144,
                    "mention": "128",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 1145,
                    "end": 1148,
                    "mention": "229",
                    "ref_id": "BIBREF145"
                },
                {
                    "start": 1149,
                    "end": 1152,
                    "mention": "230",
                    "ref_id": "BIBREF147"
                },
                {
                    "start": 1159,
                    "end": 1162,
                    "mention": "142",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 1163,
                    "end": 1166,
                    "mention": "231",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 1264,
                    "end": 1266,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 1267,
                    "end": 1270,
                    "mention": "225",
                    "ref_id": "BIBREF142"
                }
            ],
            "section": "Importance of Serotypes",
            "ref_spans": [
                {
                    "start": 91,
                    "end": 98,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "Different genome types within serotypes have been identified by restriction enzyme analysis,39\n40\n232 multiplex PCR techniques targeting fiber genes or hexon genes233 or sequencing of the fiber genes29\n234 and hexon genes.29\n31\n235 The widely used genome typing system was proposed and modified by Li et al.12\n236 The prototype AdV strain is designated \u201cp\u201d; other genome types within the serotype are designated \u201ca\u201d through \u201ck\u201d based on their distinct BamHI digestion profiles. Genome types may be further distinguished by restriction pattern with additional selected enzymes (e.g., AdV-7p, AdV-7p1, etc.).12\n40\n80 This system has been used to correlate intraserotypic genetic variability with geographic distribution and pathogenic potential.40\n",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 94,
                    "mention": "39",
                    "ref_id": "BIBREF259"
                },
                {
                    "start": 95,
                    "end": 97,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 98,
                    "end": 101,
                    "mention": "232",
                    "ref_id": "BIBREF149"
                },
                {
                    "start": 163,
                    "end": 166,
                    "mention": "233",
                    "ref_id": "BIBREF150"
                },
                {
                    "start": 199,
                    "end": 201,
                    "mention": "29",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 202,
                    "end": 205,
                    "mention": "234",
                    "ref_id": "BIBREF151"
                },
                {
                    "start": 222,
                    "end": 224,
                    "mention": "29",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 225,
                    "end": 227,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 228,
                    "end": 231,
                    "mention": "235",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 307,
                    "end": 309,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 310,
                    "end": 313,
                    "mention": "236",
                    "ref_id": "BIBREF153"
                },
                {
                    "start": 606,
                    "end": 608,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 609,
                    "end": 611,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 612,
                    "end": 614,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 743,
                    "end": 745,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                }
            ],
            "section": "Molecular Characterization of Adenovirus",
            "ref_spans": []
        },
        {
            "text": "Rapidly advancing sequencing technologies at affordable costs have allowed relatively easy access to complete genomic sequence data for human AdV strains expanding the information on the genetic makeup of several viruses of medical importance and contributing to a better understanding of AdV evolution.35\n237\n238\n239\n240\n",
            "cite_spans": [
                {
                    "start": 303,
                    "end": 305,
                    "mention": "35",
                    "ref_id": "BIBREF255"
                },
                {
                    "start": 306,
                    "end": 309,
                    "mention": "237",
                    "ref_id": "BIBREF154"
                },
                {
                    "start": 310,
                    "end": 313,
                    "mention": "238",
                    "ref_id": "BIBREF155"
                },
                {
                    "start": 314,
                    "end": 317,
                    "mention": "239",
                    "ref_id": "BIBREF156"
                },
                {
                    "start": 318,
                    "end": 321,
                    "mention": "240",
                    "ref_id": "BIBREF158"
                }
            ],
            "section": "Whole Genome Sequencing and Designation of Viruses Described by Bioinformatics Analysis of Complete Genomic Sequences",
            "ref_spans": []
        },
        {
            "text": "Novel genomes representing cases of intertypic recombination or viruses with truly novel hexon, penton base or fiber genes have been under consideration as candidate new types and designated with numbers consecutive to the original set of 51 used to designate HAdV serotypes. The criteria for designation remain a matter of active debate.241\n",
            "cite_spans": [
                {
                    "start": 338,
                    "end": 341,
                    "mention": "241",
                    "ref_id": "BIBREF159"
                }
            ],
            "section": "Whole Genome Sequencing and Designation of Viruses Described by Bioinformatics Analysis of Complete Genomic Sequences",
            "ref_spans": []
        },
        {
            "text": "The predominant serotypes detected in association with disease differ among different countries or regions, and change over time.3\n12\n31\n40\n86\n242\n243\n244\n245 Transmission of novel strains between countries or across continents and replacement of dominant serotypes by new strains may occur.33\n246\n",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 130,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 131,
                    "end": 133,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 134,
                    "end": 136,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 137,
                    "end": 139,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 140,
                    "end": 142,
                    "mention": "86",
                    "ref_id": "BIBREF311"
                },
                {
                    "start": 143,
                    "end": 146,
                    "mention": "242",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 147,
                    "end": 150,
                    "mention": "243",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 151,
                    "end": 154,
                    "mention": "244",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 155,
                    "end": 158,
                    "mention": "245",
                    "ref_id": "BIBREF163"
                },
                {
                    "start": 291,
                    "end": 293,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 294,
                    "end": 297,
                    "mention": "246",
                    "ref_id": "BIBREF164"
                }
            ],
            "section": "Global Epidemiology",
            "ref_spans": []
        },
        {
            "text": "Serotypes 1 to 7 account for > 80% of AdV infections in infants and children.31\n247 The most common serotypes reported in the United States,161 Canada,5 the United Kingdom,248 Taiwan,11 and South Korea31 are displayed in Table 1. Striking differences in distribution of serotypes have been noted in civilian and military populations161 (Table 1).",
            "cite_spans": [
                {
                    "start": 77,
                    "end": 79,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 80,
                    "end": 83,
                    "mention": "247",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 140,
                    "end": 143,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 151,
                    "end": 152,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 172,
                    "end": 175,
                    "mention": "248",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 183,
                    "end": 185,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 201,
                    "end": 203,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 332,
                    "end": 335,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                }
            ],
            "section": "Global Epidemiology",
            "ref_spans": [
                {
                    "start": 221,
                    "end": 228,
                    "mention": "Table 1",
                    "ref_id": null
                },
                {
                    "start": 337,
                    "end": 344,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "In South America, AdV-7 has been a predominant strain associated with RTI requiring hospitalization in many countries.10\n224 In Brazil, AdV-7 was the predominant serotype for decades, but an outbreak of AdV-3 occurred in 2000.10 In Asia, AdV-3 and -7 have been the predominant serotypes associated with RTI in children.3\n11\n12\n13\n249\n",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 120,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 121,
                    "end": 124,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 226,
                    "end": 228,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 319,
                    "end": 320,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 321,
                    "end": 323,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 324,
                    "end": 326,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 327,
                    "end": 329,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 330,
                    "end": 333,
                    "mention": "249",
                    "ref_id": "BIBREF167"
                }
            ],
            "section": "Global Epidemiology",
            "ref_spans": []
        },
        {
            "text": "Documented changes in relative prevalence of serotypes and genomic variants among geographic regions underscore the potential for new strains to emerge and replace existing strains.10\n11\n12\n40\n65\n244\n246\n250\n251\n252 For interested readers, we discussed the epidemiology and temporal changes in circulating genomic variants globally in greater detail in a review in 2011.1\n",
            "cite_spans": [
                {
                    "start": 181,
                    "end": 183,
                    "mention": "10",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 184,
                    "end": 186,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 187,
                    "end": 189,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 190,
                    "end": 192,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 193,
                    "end": 195,
                    "mention": "65",
                    "ref_id": "BIBREF288"
                },
                {
                    "start": 196,
                    "end": 199,
                    "mention": "244",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 200,
                    "end": 203,
                    "mention": "246",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 204,
                    "end": 207,
                    "mention": "250",
                    "ref_id": "BIBREF169"
                },
                {
                    "start": 208,
                    "end": 211,
                    "mention": "251",
                    "ref_id": "BIBREF170"
                },
                {
                    "start": 212,
                    "end": 215,
                    "mention": "252",
                    "ref_id": "BIBREF171"
                },
                {
                    "start": 370,
                    "end": 371,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Global Epidemiology",
            "ref_spans": []
        },
        {
            "text": "Given the large number of AdV serotypes, a discussion of each serotype is beyond the scope of this review. However, we will discuss a few of the commonly detected serotypes (e.g., AdV-1, -2, -3, -4, -7, and -21), additional serotypes associated with specific clinical syndromes (e.g., AdV-8, -37, -40, -41, and -55) and the recent emergence of AdV-14 in the United States.",
            "cite_spans": [],
            "section": "Epidemiology and Characteristics of Specific Serotypes",
            "ref_spans": []
        },
        {
            "text": "Serotypes AdV-1 and -2 (both species C) are common causes of acute FRI worldwide, but appear to be less virulent than AdV-711\n224\n246 or -3.88\n224 However, a nosocomial outbreak of severe pneumonia in immunocompetent hosts due to AdV-1 was recently described in France.253 The prevalence of AdV-1 and -2 varies among different geographic regions and populations. In the United States (2004\u20132006), AdV-1 and -2 accounted for 17.6 and 24.3% of AdV clinical respiratory isolates among civilians (children or adults), respectively, but only 0.4 and 0.4% among military recruits.161 The prevalence of these serotypes at other sites is variable: that is, Toronto, Canada (2007\u20132008), AdV-1 (18%); AdV-2 (26%)5; United Kingdom (1982\u20131996), AdV-1 (12.1%); AdV-2 (18.6%)248; Buenos Aires (1984\u20131988); AdV-1 (10%); AdV-2 (20%)246; Seoul, Korea (1990\u201398); AdV-1 (9.2%); AdV-2 (11.2%).88\n",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 125,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 126,
                    "end": 129,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 130,
                    "end": 133,
                    "mention": "246",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 140,
                    "end": 142,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 143,
                    "end": 146,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 269,
                    "end": 272,
                    "mention": "253",
                    "ref_id": "BIBREF172"
                },
                {
                    "start": 574,
                    "end": 577,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 702,
                    "end": 703,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 761,
                    "end": 764,
                    "mention": "248",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 816,
                    "end": 819,
                    "mention": "246",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 873,
                    "end": 875,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                }
            ],
            "section": "Adenovirus Serotypes 1 and 2",
            "ref_spans": []
        },
        {
            "text": "Globally, AdV-3 is among the most common serotypes implicated in AdV infections in children and adults.3\n84\n161\n251 AdV accounted for 13% of AdV respiratory isolates reported to the World Health Organization from 1967 to 197684 and remains a cause of endemic and epidemic infections3\n5\n19\n161\n248 (Table 1). In the United States and southern Ontario from 2004 to 2006, AdV-3 accounted for 34.6% of AdV RTI in civilians but only 2.6% among military trainees.161 The prevalence of AdV-3 at other sites is variable: that is, Toronto, Canada (2007\u20132008), (46%)5; United Kingdom (1982\u20131996), (14.9%)248; Seoul, Korea (1990\u20131998), (15%)88; Seoul, Korea (1991\u20132007), (37.0%).31 In Taiwan, AdV-3 was the predominant serotype in 1981\u20131989 (68%) and 1990\u20131998 (44%) but decreased to 2% of respiratory isolates in 2001 (largely replaced by AdV-4 and -711). During an outbreak of respiratory AdV infections in children from November 2004 to February 2005 in Taiwan, AdV-3 was implicated in 87.5% of the cases.3 AdV-3 may cause fatal pneumonias in immunocompetent children249\n254 and adults.65 AdV-3 and a recombinant strain of AdV-3/7 were responsible for an outbreak of FRIs (including two fatalities) in children in Portugal in 2004.254\n",
            "cite_spans": [
                {
                    "start": 103,
                    "end": 104,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 105,
                    "end": 107,
                    "mention": "84",
                    "ref_id": "BIBREF309"
                },
                {
                    "start": 108,
                    "end": 111,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 112,
                    "end": 115,
                    "mention": "251",
                    "ref_id": "BIBREF170"
                },
                {
                    "start": 225,
                    "end": 227,
                    "mention": "84",
                    "ref_id": "BIBREF309"
                },
                {
                    "start": 282,
                    "end": 283,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 284,
                    "end": 285,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 286,
                    "end": 288,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 289,
                    "end": 292,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 293,
                    "end": 296,
                    "mention": "248",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 457,
                    "end": 460,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 556,
                    "end": 557,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 594,
                    "end": 597,
                    "mention": "248",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 630,
                    "end": 632,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 668,
                    "end": 670,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 841,
                    "end": 843,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 997,
                    "end": 998,
                    "mention": "3",
                    "ref_id": "BIBREF223"
                },
                {
                    "start": 1059,
                    "end": 1062,
                    "mention": "249",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 1063,
                    "end": 1066,
                    "mention": "254",
                    "ref_id": "BIBREF173"
                },
                {
                    "start": 1078,
                    "end": 1080,
                    "mention": "65",
                    "ref_id": "BIBREF288"
                },
                {
                    "start": 1223,
                    "end": 1226,
                    "mention": "254",
                    "ref_id": "BIBREF173"
                }
            ],
            "section": "Adenovirus Serotype 3",
            "ref_spans": [
                {
                    "start": 298,
                    "end": 305,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "AdV-4 is a cause of sporadic infections in civilians5 and has been implicated in epidemic outbreaks of FRI or pneumonia in civilian11\n255 and military18\n20\n74\n177 populations. In civilian populations, AdV-4 was implicated in 4.8% of AdV RTI in the United States (2004\u20132006)161; 1% in Toronto, Canada (2007\u20132008)5; 3.9% (pediatric isolates) in South Korea (1991\u20131997).31 In Taiwan, AdV-4 accounted for 29% of pediatric respiratory isolates from 1981\u20132001, and became the predominant serotype (52%) in 2001.11 Until recently, AdV-4 was the most common serotype associated with FRI in military recruits in the United States.18\n80\n177\n256 The strategy of vaccinating all military recruits against AdV-4 and -7 beginning in 1971174\n257 eliminated both serotypes as causes of epidemic of FRI in the military for more than two decades.80 After the vaccine was depleted, an outbreak of AdV-4 occurred at an Army basic training site in 1997.74 Over the next several years, AdV-4 spread to multiple secondary sites.20 From 1999 to 2004, AdV-4 accounted for > 95% of AdV FRI among military recruits in the United States.20 By 2006 to 2007 the emerging AdV-14 largely replaced AdV-4 as a cause of AdV FRI among military recruits in the United States.33 After a 12-year interruption in vaccination the original vaccine formulation was reintroduced in October of 2011 resulting in a dramatic decline in the rates of AdV-associated febrile illness among recruits in training.175\n",
            "cite_spans": [
                {
                    "start": 52,
                    "end": 53,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 131,
                    "end": 133,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 134,
                    "end": 137,
                    "mention": "255",
                    "ref_id": "BIBREF174"
                },
                {
                    "start": 150,
                    "end": 152,
                    "mention": "18",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 153,
                    "end": 155,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 156,
                    "end": 158,
                    "mention": "74",
                    "ref_id": "BIBREF298"
                },
                {
                    "start": 159,
                    "end": 162,
                    "mention": "177",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 273,
                    "end": 276,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 311,
                    "end": 312,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 367,
                    "end": 369,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 505,
                    "end": 507,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 621,
                    "end": 623,
                    "mention": "18",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 624,
                    "end": 626,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 627,
                    "end": 630,
                    "mention": "177",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 631,
                    "end": 634,
                    "mention": "256",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 723,
                    "end": 726,
                    "mention": "174",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 727,
                    "end": 730,
                    "mention": "257",
                    "ref_id": "BIBREF176"
                },
                {
                    "start": 828,
                    "end": 830,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 932,
                    "end": 934,
                    "mention": "74",
                    "ref_id": "BIBREF298"
                },
                {
                    "start": 1005,
                    "end": 1007,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 1109,
                    "end": 1111,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 1238,
                    "end": 1240,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 1460,
                    "end": 1463,
                    "mention": "175",
                    "ref_id": "BIBREF87"
                }
            ],
            "section": "Adenovirus Serotype 4",
            "ref_spans": []
        },
        {
            "text": "Globally, AdV-7 was the third most common serotype reported to the World Health Organization from 1967 through 1976, following AdV-1 and -284 and remains one of the leading serotypes detected in association with disease globally.31\n40\n258 AdV-7 infections manifest as FRI, pharyngoconjunctival fever, bronchitis, necrotizing bronchiolitis, or pneumonia.40\n224\n259 AdV-7 appears to be more virulent than other serotypes.11\n88\n224\n242\n249\n260\n261\n262 Fatal pneumonias may occur in immunocompetent children6\n224\n250\n263\n264 and adults.23\n265\n",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 141,
                    "mention": "84",
                    "ref_id": "BIBREF309"
                },
                {
                    "start": 229,
                    "end": 231,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 232,
                    "end": 234,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 235,
                    "end": 238,
                    "mention": "258",
                    "ref_id": "BIBREF177"
                },
                {
                    "start": 353,
                    "end": 355,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 356,
                    "end": 359,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 360,
                    "end": 363,
                    "mention": "259",
                    "ref_id": "BIBREF178"
                },
                {
                    "start": 419,
                    "end": 421,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 422,
                    "end": 424,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 425,
                    "end": 428,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 429,
                    "end": 432,
                    "mention": "242",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 433,
                    "end": 436,
                    "mention": "249",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 437,
                    "end": 440,
                    "mention": "260",
                    "ref_id": "BIBREF180"
                },
                {
                    "start": 441,
                    "end": 444,
                    "mention": "261",
                    "ref_id": "BIBREF181"
                },
                {
                    "start": 445,
                    "end": 448,
                    "mention": "262",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 503,
                    "end": 504,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 505,
                    "end": 508,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 509,
                    "end": 512,
                    "mention": "250",
                    "ref_id": "BIBREF169"
                },
                {
                    "start": 513,
                    "end": 516,
                    "mention": "263",
                    "ref_id": "BIBREF183"
                },
                {
                    "start": 517,
                    "end": 520,
                    "mention": "264",
                    "ref_id": "BIBREF184"
                },
                {
                    "start": 532,
                    "end": 534,
                    "mention": "23",
                    "ref_id": "BIBREF146"
                },
                {
                    "start": 535,
                    "end": 538,
                    "mention": "265",
                    "ref_id": "BIBREF185"
                }
            ],
            "section": "Adenovirus Serotype 7",
            "ref_spans": []
        },
        {
            "text": "Epidemic AdV-7 infections have been reported in the United States,6\n264\n266 Canada,263 Latin America,224\n267 Australia,268 Israel,243 Korea,75\n88 Japan,242\n259 China,12\n262 the Philippines,261 and globally.161\n243 Outbreaks typically occur in closed settings (e.g., military barracks18\n39; chronic care facilities80; hospitals6\n78\n269\n270). In the late 1960s, AdV-7 and -4 accounted for most cases of FRI among military recruits in the United States.80\n256 Following routine vaccination of military recruits in the United States beginning in 1971,174\n257 no epidemics of FRI were attributed to AdV-7 or -4 from 1984 through 1994.80 However, in 1997 (after the vaccine supply was depleted), an epidemic (> 500 cases) of AdV FRI in a U. S. Navy training site was attributed to serotypes AdV-7 (70%) and AdV-3 (24%), respectively.19 Since 2007, AdV-7 has largely disappeared as a cause of FRI in U. S. military settings (possibly replaced by AdV-14).33\n",
            "cite_spans": [
                {
                    "start": 66,
                    "end": 67,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 68,
                    "end": 71,
                    "mention": "264",
                    "ref_id": "BIBREF184"
                },
                {
                    "start": 72,
                    "end": 75,
                    "mention": "266",
                    "ref_id": "BIBREF186"
                },
                {
                    "start": 83,
                    "end": 86,
                    "mention": "263",
                    "ref_id": "BIBREF183"
                },
                {
                    "start": 101,
                    "end": 104,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 105,
                    "end": 108,
                    "mention": "267",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 119,
                    "end": 122,
                    "mention": "268",
                    "ref_id": "BIBREF188"
                },
                {
                    "start": 130,
                    "end": 133,
                    "mention": "243",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 140,
                    "end": 142,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 143,
                    "end": 145,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 152,
                    "end": 155,
                    "mention": "242",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 156,
                    "end": 159,
                    "mention": "259",
                    "ref_id": "BIBREF178"
                },
                {
                    "start": 166,
                    "end": 168,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 169,
                    "end": 172,
                    "mention": "262",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 189,
                    "end": 192,
                    "mention": "261",
                    "ref_id": "BIBREF181"
                },
                {
                    "start": 206,
                    "end": 209,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 210,
                    "end": 213,
                    "mention": "243",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 283,
                    "end": 285,
                    "mention": "18",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 286,
                    "end": 288,
                    "mention": "39",
                    "ref_id": "BIBREF259"
                },
                {
                    "start": 313,
                    "end": 315,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 326,
                    "end": 327,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 328,
                    "end": 330,
                    "mention": "78",
                    "ref_id": "BIBREF302"
                },
                {
                    "start": 331,
                    "end": 334,
                    "mention": "269",
                    "ref_id": "BIBREF189"
                },
                {
                    "start": 335,
                    "end": 338,
                    "mention": "270",
                    "ref_id": "BIBREF191"
                },
                {
                    "start": 450,
                    "end": 452,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 453,
                    "end": 456,
                    "mention": "256",
                    "ref_id": "BIBREF175"
                },
                {
                    "start": 547,
                    "end": 550,
                    "mention": "174",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 551,
                    "end": 554,
                    "mention": "257",
                    "ref_id": "BIBREF176"
                },
                {
                    "start": 629,
                    "end": 631,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 827,
                    "end": 829,
                    "mention": "19",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 947,
                    "end": 949,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                }
            ],
            "section": "Adenovirus Serotype 7",
            "ref_spans": []
        },
        {
            "text": "The prevalence of AdV-7 varies according to geographic regions and over time, and depends on strain genome type, herd immunity in the region, and epidemiological settings.6\n80\n161\n264 In the United States from 2004 to 2006, AdV-7 accounted for only 5/581 (0.9%) of clinical AdV respiratory isolates in military facilities and 48/1,653 (2.9%) isolates in civilian settings.161 By contrast, AdV-7 was a prominent cause of FRI in South America in the 1990s224\n267 and Asia.12\n13\n31\n88\n242\n258 AdV-7 has been recently reported in association with severe disease in several provinces of China.262\n265\n271 AdV-7 was the leading cause of death due to AdV pneumonia in South America in the 1980s and 1990s.224\n267 In a study of 165 AdV RTIs in children in Argentina and Uruguay, AdV-7 accounted for 62.2% of isolates and was responsible for 17 of 18 fatalities.224 The prevalence of AdV-7 as a cause of AdV FRI is Asia is variable, ranging from < 1242 to > 60%.75 In Seoul, Korea from 1990 to 1998, AdV-7 accounted for 41% of RTI (followed by AdV-3 [15%] and AdV-2 [15%]).88 From 1991 to 2007 in Seoul, AdV-7 accounted for 23.3% of pediatric respiratory AdV isolates, second only to AdV-3 (37.0%) (Table 1).31 In a survey of 200 military recruits in South Korea in 2006, 122 recruits (61%) developed AdV infections; all 122 isolates were AdV-7.75 In Taiwan, AdV-7 emerged as the predominant serotype (45%) in 1999 to 2000, but fell drastically to 1% in 2001 (replaced by AdV-4).11 In Beijing, China, AdV-7 and -3 were the most common serotypes causing pneumonia from 1958 to 1990.12\n",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 172,
                    "mention": "6",
                    "ref_id": "BIBREF282"
                },
                {
                    "start": 173,
                    "end": 175,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 176,
                    "end": 179,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 180,
                    "end": 183,
                    "mention": "264",
                    "ref_id": "BIBREF184"
                },
                {
                    "start": 372,
                    "end": 375,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 453,
                    "end": 456,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 457,
                    "end": 460,
                    "mention": "267",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 470,
                    "end": 472,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 473,
                    "end": 475,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 476,
                    "end": 478,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 479,
                    "end": 481,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 482,
                    "end": 485,
                    "mention": "242",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 486,
                    "end": 489,
                    "mention": "258",
                    "ref_id": "BIBREF177"
                },
                {
                    "start": 588,
                    "end": 591,
                    "mention": "262",
                    "ref_id": "BIBREF182"
                },
                {
                    "start": 592,
                    "end": 595,
                    "mention": "265",
                    "ref_id": "BIBREF185"
                },
                {
                    "start": 596,
                    "end": 599,
                    "mention": "271",
                    "ref_id": "BIBREF192"
                },
                {
                    "start": 698,
                    "end": 701,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 702,
                    "end": 705,
                    "mention": "267",
                    "ref_id": "BIBREF187"
                },
                {
                    "start": 853,
                    "end": 856,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 940,
                    "end": 943,
                    "mention": "242",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 953,
                    "end": 955,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 1064,
                    "end": 1066,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 1199,
                    "end": 1201,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 1336,
                    "end": 1338,
                    "mention": "75",
                    "ref_id": "BIBREF299"
                },
                {
                    "start": 1470,
                    "end": 1472,
                    "mention": "11",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 1572,
                    "end": 1574,
                    "mention": "12",
                    "ref_id": "BIBREF26"
                }
            ],
            "section": "Adenovirus Serotype 7",
            "ref_spans": [
                {
                    "start": 1190,
                    "end": 1197,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "At least 27 genome types of AdV-7 have been identified by restriction enzyme fragment analysis80; shifts or replacement of predominant genome types may occur.40\n161\n243\n244 In some cases, new genomic variants exhibit an apparent heightened virulence or transmissibility compared with earlier strains. For interested readers, the epidemiology, global shifts, and changing genotypes of AdV-7 were discussed in detail in our previous review.1\n",
            "cite_spans": [
                {
                    "start": 94,
                    "end": 96,
                    "mention": "80",
                    "ref_id": "BIBREF305"
                },
                {
                    "start": 158,
                    "end": 160,
                    "mention": "40",
                    "ref_id": "BIBREF261"
                },
                {
                    "start": 161,
                    "end": 164,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 165,
                    "end": 168,
                    "mention": "243",
                    "ref_id": "BIBREF161"
                },
                {
                    "start": 169,
                    "end": 172,
                    "mention": "244",
                    "ref_id": "BIBREF162"
                },
                {
                    "start": 438,
                    "end": 439,
                    "mention": "1",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Adenovirus Serotype 7",
            "ref_spans": []
        },
        {
            "text": "AdV-8 accounts for < 1% of AdV infections,5\n31\n88\n161 but is a common cause of EKC.88\n105\n107\n111\n116\n272\n273 In four studies in Asia and the Middle East, AdV-8 accounted for 64 to 79% of EKC due to AdV.105\n106\n109\n117 In a neonatal intensive care unit in Turkey, cases of conjunctivitis due to AdV-8 were linked to a contaminated eyelid speculum.272\n",
            "cite_spans": [
                {
                    "start": 42,
                    "end": 43,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 44,
                    "end": 46,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 47,
                    "end": 49,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 50,
                    "end": 53,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 83,
                    "end": 85,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 86,
                    "end": 89,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 90,
                    "end": 93,
                    "mention": "107",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 94,
                    "end": 97,
                    "mention": "111",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 98,
                    "end": 101,
                    "mention": "116",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 102,
                    "end": 105,
                    "mention": "272",
                    "ref_id": "BIBREF193"
                },
                {
                    "start": 106,
                    "end": 109,
                    "mention": "273",
                    "ref_id": "BIBREF194"
                },
                {
                    "start": 203,
                    "end": 206,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 207,
                    "end": 210,
                    "mention": "106",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 211,
                    "end": 214,
                    "mention": "109",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 215,
                    "end": 218,
                    "mention": "117",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 347,
                    "end": 350,
                    "mention": "272",
                    "ref_id": "BIBREF193"
                }
            ],
            "section": "Adenovirus Serotype 8",
            "ref_spans": []
        },
        {
            "text": "AdV-11 is relatively uncommon, but may cause hemorrhagic conjunctivitis45\n46\n47\n81 and FRI (including pneumonia) in immunocompetent patients and HC in immunocompromised patients.21\n81 In the United States from 2004 to 2006, AdV-11 accounted for < 1% of AdV RTI in military recruits and civilians161; in Toronto, Canada, AdV-11 was not detected among 96 clinical respiratory AdV isolates (Table 1). AdV-11 comprised 3.4% of 741 pediatric respiratory isolates from Korea from 1991 to 2007.31 Outbreaks of AdV-11 FRIs were described in South America,224 United States,21\n274 Asia,44\n81 the Middle East,223 and globally. AdV-11 may cause UTI, including HC, in organ transplant recipients (particularly children).2\n71\n139\n275\n",
            "cite_spans": [
                {
                    "start": 71,
                    "end": 73,
                    "mention": "45",
                    "ref_id": "BIBREF266"
                },
                {
                    "start": 74,
                    "end": 76,
                    "mention": "46",
                    "ref_id": "BIBREF267"
                },
                {
                    "start": 77,
                    "end": 79,
                    "mention": "47",
                    "ref_id": "BIBREF268"
                },
                {
                    "start": 80,
                    "end": 82,
                    "mention": "81",
                    "ref_id": "BIBREF306"
                },
                {
                    "start": 178,
                    "end": 180,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 181,
                    "end": 183,
                    "mention": "81",
                    "ref_id": "BIBREF306"
                },
                {
                    "start": 295,
                    "end": 298,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 487,
                    "end": 489,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 547,
                    "end": 550,
                    "mention": "224",
                    "ref_id": "BIBREF141"
                },
                {
                    "start": 565,
                    "end": 567,
                    "mention": "21",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 568,
                    "end": 571,
                    "mention": "274",
                    "ref_id": "BIBREF195"
                },
                {
                    "start": 577,
                    "end": 579,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 580,
                    "end": 582,
                    "mention": "81",
                    "ref_id": "BIBREF306"
                },
                {
                    "start": 599,
                    "end": 602,
                    "mention": "223",
                    "ref_id": "BIBREF140"
                },
                {
                    "start": 708,
                    "end": 709,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 710,
                    "end": 712,
                    "mention": "71",
                    "ref_id": "BIBREF295"
                },
                {
                    "start": 713,
                    "end": 716,
                    "mention": "139",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 717,
                    "end": 720,
                    "mention": "275",
                    "ref_id": "BIBREF196"
                }
            ],
            "section": "Adenovirus Serotype 11",
            "ref_spans": [
                {
                    "start": 388,
                    "end": 395,
                    "mention": "Table 1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "AdV-14 was first isolated in the Netherlands in 1955 during an outbreak of acute respiratory disease (ARD) among military recruits.33 Subsequent outbreaks of ARD were described in Great Britain in 1955,276 Uzbekistan in 1962,33 and Czechoslovakia in 1963.33 Apart from sporadic cases in the Netherlands in the early 1970s, no cases of AdV-14 infections were reported globally between the 1960s and 2004.13\n33 AdV-14 had never been identified in North America before 2006.41 Beginning in March 2006, outbreaks of FRI due to AdV-14 (several hundred cases) were noted in several military bases in the United States68\n86\n274\n277 and among health care workers.68 By 2007, outbreaks in civilian populations were documented in at least 15 states.24\n33\n221\n222\n278 The severity of FRIs was variable, but fatal pneumonias were reported.24\n33\n68\n221\n278 By 2007, AdV-14 had replaced AdV-4 as the dominant serotype on U. S. military bases.41\n274 Analysis of 99 isolates recovered from patients (military and civilian) with AdV FRI between December 2003 and June 2009 from different geographic locations confirmed that all isolates were identical.33 These isolates represented a new genomic type designated AdV-14p1 (formerly known as 14a).33 The complete genetic sequence of AdV-14p1 indicates a close relationship to AdV-11a, suggesting recombination between AdV-14 and -11 strains.41 AdV-14p1 was implicated in outbreaks of severe pneumonias in the United States33 and Ireland.279 AdV-14p1 has an increased potential for high attack rates and rates of transmission, owing to the lack of herd immunity.41\n",
            "cite_spans": [
                {
                    "start": 131,
                    "end": 133,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 202,
                    "end": 205,
                    "mention": "276",
                    "ref_id": "BIBREF197"
                },
                {
                    "start": 225,
                    "end": 227,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 255,
                    "end": 257,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 403,
                    "end": 405,
                    "mention": "13",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 406,
                    "end": 408,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 471,
                    "end": 473,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                },
                {
                    "start": 611,
                    "end": 613,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 614,
                    "end": 616,
                    "mention": "86",
                    "ref_id": "BIBREF311"
                },
                {
                    "start": 617,
                    "end": 620,
                    "mention": "274",
                    "ref_id": "BIBREF195"
                },
                {
                    "start": 621,
                    "end": 624,
                    "mention": "277",
                    "ref_id": "BIBREF198"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 739,
                    "end": 741,
                    "mention": "24",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 742,
                    "end": 744,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 745,
                    "end": 748,
                    "mention": "221",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 749,
                    "end": 752,
                    "mention": "222",
                    "ref_id": "BIBREF139"
                },
                {
                    "start": 753,
                    "end": 756,
                    "mention": "278",
                    "ref_id": "BIBREF199"
                },
                {
                    "start": 827,
                    "end": 829,
                    "mention": "24",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 830,
                    "end": 832,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 833,
                    "end": 835,
                    "mention": "68",
                    "ref_id": "BIBREF291"
                },
                {
                    "start": 836,
                    "end": 839,
                    "mention": "221",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 840,
                    "end": 843,
                    "mention": "278",
                    "ref_id": "BIBREF199"
                },
                {
                    "start": 928,
                    "end": 930,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                },
                {
                    "start": 931,
                    "end": 934,
                    "mention": "274",
                    "ref_id": "BIBREF195"
                },
                {
                    "start": 1135,
                    "end": 1137,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 1228,
                    "end": 1230,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 1372,
                    "end": 1374,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                },
                {
                    "start": 1453,
                    "end": 1455,
                    "mention": "33",
                    "ref_id": "BIBREF253"
                },
                {
                    "start": 1468,
                    "end": 1471,
                    "mention": "279",
                    "ref_id": "BIBREF200"
                },
                {
                    "start": 1592,
                    "end": 1594,
                    "mention": "41",
                    "ref_id": "BIBREF262"
                }
            ],
            "section": "Adenovirus Serotype 14",
            "ref_spans": []
        },
        {
            "text": "AdV-21 was associated with epidemics of FRIs in military recruits in the Netherlands in the 1960s,280 but only sporadic cases were reported over the next two decades.281 In 1984 and 1985, outbreaks of AdV-21 infections in children in the Netherlands and Germany were published.281 AdV-21 has been associated with pharyngitis and conjunctivitis282 and FRI228 but is uncommon.31 In the United States from 2004 to 2006, AdV-21 accounted for 2.0 and 2.4% of AdV RTI in civilians and military recruits, respectively.161 In Toronto, Canada (2007\u20132008), AdV-21 accounted for 5.5% of clinical respiratory AdV isolates. By contrast, AdV-21 was never isolated in 741 pediatric respiratory isolates from Korea from 1991 to 2007.31 Interestingly, Adv-21 may be less transmissible than other AdV serotypes.283 However, a highly virulent strain of AdV-21 was associated with severe pneumonia cases in Germany34 and neurological284 and cardiac285 manifestations in Malaysia. Similar strains were found to circulate in the United States over the last 3 decades39 with no apparent association with severe disease among the infected young adults.",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 101,
                    "mention": "280",
                    "ref_id": "BIBREF202"
                },
                {
                    "start": 166,
                    "end": 169,
                    "mention": "281",
                    "ref_id": "BIBREF203"
                },
                {
                    "start": 277,
                    "end": 280,
                    "mention": "281",
                    "ref_id": "BIBREF203"
                },
                {
                    "start": 343,
                    "end": 346,
                    "mention": "282",
                    "ref_id": "BIBREF204"
                },
                {
                    "start": 354,
                    "end": 357,
                    "mention": "228",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 374,
                    "end": 376,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 511,
                    "end": 514,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 717,
                    "end": 719,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 793,
                    "end": 796,
                    "mention": "283",
                    "ref_id": "BIBREF205"
                },
                {
                    "start": 894,
                    "end": 896,
                    "mention": "34",
                    "ref_id": "BIBREF254"
                },
                {
                    "start": 913,
                    "end": 916,
                    "mention": "284",
                    "ref_id": "BIBREF206"
                },
                {
                    "start": 928,
                    "end": 931,
                    "mention": "285",
                    "ref_id": "BIBREF207"
                },
                {
                    "start": 1044,
                    "end": 1046,
                    "mention": "39",
                    "ref_id": "BIBREF259"
                }
            ],
            "section": "Adenovirus Serotype 21",
            "ref_spans": []
        },
        {
            "text": "AdV-31 may cause gastroenteritis in healthy children, and has been associated with severe (sometimes) fatal infections in HSCT recipients.28\n157\n286\n287\n288 Nosocomial transmission (seven cases) in a pediatric SCT unit was described.288\n",
            "cite_spans": [
                {
                    "start": 138,
                    "end": 140,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 141,
                    "end": 144,
                    "mention": "157",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 145,
                    "end": 148,
                    "mention": "286",
                    "ref_id": "BIBREF208"
                },
                {
                    "start": 149,
                    "end": 152,
                    "mention": "287",
                    "ref_id": "BIBREF209"
                },
                {
                    "start": 153,
                    "end": 156,
                    "mention": "288",
                    "ref_id": "BIBREF210"
                },
                {
                    "start": 233,
                    "end": 236,
                    "mention": "288",
                    "ref_id": "BIBREF210"
                }
            ],
            "section": "Adenovirus Serotype 31",
            "ref_spans": []
        },
        {
            "text": "AdV-37 accounts for < 1% of AdV infections,5\n31\n88\n161 but may cause EKC.88\n103\n105\n106\n107\n108\n109\n",
            "cite_spans": [
                {
                    "start": 43,
                    "end": 44,
                    "mention": "5",
                    "ref_id": "BIBREF271"
                },
                {
                    "start": 45,
                    "end": 47,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 48,
                    "end": 50,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 51,
                    "end": 54,
                    "mention": "161",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 73,
                    "end": 75,
                    "mention": "88",
                    "ref_id": "BIBREF313"
                },
                {
                    "start": 76,
                    "end": 79,
                    "mention": "103",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 80,
                    "end": 83,
                    "mention": "105",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 84,
                    "end": 87,
                    "mention": "106",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 88,
                    "end": 91,
                    "mention": "107",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 92,
                    "end": 95,
                    "mention": "108",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 96,
                    "end": 99,
                    "mention": "109",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Adenovirus Serotype 37",
            "ref_spans": []
        },
        {
            "text": "AdV of species F (serotypes 40 and 41) typically cause gastroenteritis and diarrheal illness in children.50\n51\n52\n53\n54\n55\n56\n57\n58\n59\n60\n61 Fatalities may occur as a result of dehydration in infants.50\n51 In immunocompromised hosts, fatal dissemination may occur.73\n289 Epidemics have been cited in schools56 and hospitals.73 Endogenous reactivation originating from AdV persistent in mucosal lymphoid cells may occur.70 Nosocomial transmission may occur due to high AdV levels in feces.73 Shedding of these viruses may be prolonged in immunosuppressed patients.73\n",
            "cite_spans": [
                {
                    "start": 105,
                    "end": 107,
                    "mention": "50",
                    "ref_id": "BIBREF272"
                },
                {
                    "start": 108,
                    "end": 110,
                    "mention": "51",
                    "ref_id": "BIBREF273"
                },
                {
                    "start": 111,
                    "end": 113,
                    "mention": "52",
                    "ref_id": "BIBREF274"
                },
                {
                    "start": 114,
                    "end": 116,
                    "mention": "53",
                    "ref_id": "BIBREF275"
                },
                {
                    "start": 117,
                    "end": 119,
                    "mention": "54",
                    "ref_id": "BIBREF276"
                },
                {
                    "start": 120,
                    "end": 122,
                    "mention": "55",
                    "ref_id": "BIBREF277"
                },
                {
                    "start": 123,
                    "end": 125,
                    "mention": "56",
                    "ref_id": "BIBREF278"
                },
                {
                    "start": 126,
                    "end": 128,
                    "mention": "57",
                    "ref_id": "BIBREF279"
                },
                {
                    "start": 129,
                    "end": 131,
                    "mention": "58",
                    "ref_id": "BIBREF280"
                },
                {
                    "start": 132,
                    "end": 134,
                    "mention": "59",
                    "ref_id": "BIBREF281"
                },
                {
                    "start": 135,
                    "end": 137,
                    "mention": "60",
                    "ref_id": "BIBREF283"
                },
                {
                    "start": 138,
                    "end": 140,
                    "mention": "61",
                    "ref_id": "BIBREF284"
                },
                {
                    "start": 200,
                    "end": 202,
                    "mention": "50",
                    "ref_id": "BIBREF272"
                },
                {
                    "start": 203,
                    "end": 205,
                    "mention": "51",
                    "ref_id": "BIBREF273"
                },
                {
                    "start": 264,
                    "end": 266,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                },
                {
                    "start": 267,
                    "end": 270,
                    "mention": "289",
                    "ref_id": "BIBREF211"
                },
                {
                    "start": 307,
                    "end": 309,
                    "mention": "56",
                    "ref_id": "BIBREF278"
                },
                {
                    "start": 324,
                    "end": 326,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                },
                {
                    "start": 419,
                    "end": 421,
                    "mention": "70",
                    "ref_id": "BIBREF294"
                },
                {
                    "start": 488,
                    "end": 490,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                },
                {
                    "start": 563,
                    "end": 565,
                    "mention": "73",
                    "ref_id": "BIBREF297"
                }
            ],
            "section": "Adenovirus of Species F (Serotypes 40 and 41)",
            "ref_spans": []
        },
        {
            "text": "Infections due to AdV-55 of species B are rare, but this virus has been implicated in outbreaks of severe pneumonia and acute respiratory distress syndrome in China since 2006.89\n91\n290\n291 This type is an intertypic recombinant with an AdV-11-like hexon gene and an AdV-14-like fiber gene.240 Several reports describing cases of respiratory infection by this unique AdV under other designations (AdV-11, 14\u201311 or genome type 11a, depending on the typing approach) can be found in the literature.44\n292\n293\n294\n",
            "cite_spans": [
                {
                    "start": 176,
                    "end": 178,
                    "mention": "89",
                    "ref_id": "BIBREF314"
                },
                {
                    "start": 179,
                    "end": 181,
                    "mention": "91",
                    "ref_id": "BIBREF317"
                },
                {
                    "start": 182,
                    "end": 185,
                    "mention": "290",
                    "ref_id": "BIBREF213"
                },
                {
                    "start": 186,
                    "end": 189,
                    "mention": "291",
                    "ref_id": "BIBREF214"
                },
                {
                    "start": 290,
                    "end": 293,
                    "mention": "240",
                    "ref_id": "BIBREF158"
                },
                {
                    "start": 496,
                    "end": 498,
                    "mention": "44",
                    "ref_id": "BIBREF265"
                },
                {
                    "start": 499,
                    "end": 502,
                    "mention": "292",
                    "ref_id": "BIBREF215"
                },
                {
                    "start": 503,
                    "end": 506,
                    "mention": "293",
                    "ref_id": "BIBREF216"
                },
                {
                    "start": 507,
                    "end": 510,
                    "mention": "294",
                    "ref_id": "BIBREF217"
                }
            ],
            "section": "Adenovirus Genotype 55",
            "ref_spans": []
        },
        {
            "text": "AdV can be detected in affected sites (e.g., nasopharyngeal aspirates, swabs, washings, bronchoalveolar lavage, urine, stool, blood) by direct or indirect immunofluorescence, conventional or shell vial cultures, or PCR.31 Viral cultures by conventional techniques are the gold standard, but could be insensitive for certain samples (e.g., blood) and may take up to 21 days to develop the cytopathic effect.2\n31 Biopsy of involved tissues may reveal AdV nuclear inclusions2; immunohistochemical stains may identify the AdV hexon antigen in tissue.146 PCR of AdV DNA in plasma, urine, or other clinical specimens is currently the most frequently used approach to establish the diagnosis,2\n194 and is highly sensitive for disseminated disease.295\n296 Quantification of the viral load using real-time PCR is a useful marker to assess response to therapy.189\n295 Among transplant recipients, serial PCR assays of blood and stool weekly may detect AdV disease before the onset of symptoms, and facilitate early \u201cpreemptive\u201d therapy.26\n153\n188\n196 In one study of 138 pediatric allogeneic SCT recipients, AdV was detected in stool samples at median of 11 days before AdV viremia.297 The role of routine surveillance is controversial although it has been increasingly used in high-risk patients (particularly HSCT recipients2). Quantitative viral loads may not correlate with clinical presentation or disease severity.43\n",
            "cite_spans": [
                {
                    "start": 219,
                    "end": 221,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 406,
                    "end": 407,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 408,
                    "end": 410,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 471,
                    "end": 472,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 546,
                    "end": 549,
                    "mention": "146",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 685,
                    "end": 686,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 687,
                    "end": 690,
                    "mention": "194",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 740,
                    "end": 743,
                    "mention": "295",
                    "ref_id": "BIBREF218"
                },
                {
                    "start": 744,
                    "end": 747,
                    "mention": "296",
                    "ref_id": "BIBREF219"
                },
                {
                    "start": 850,
                    "end": 853,
                    "mention": "189",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 854,
                    "end": 857,
                    "mention": "295",
                    "ref_id": "BIBREF218"
                },
                {
                    "start": 1026,
                    "end": 1028,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 1029,
                    "end": 1032,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1033,
                    "end": 1036,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 1037,
                    "end": 1040,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 1172,
                    "end": 1175,
                    "mention": "297",
                    "ref_id": "BIBREF220"
                },
                {
                    "start": 1316,
                    "end": 1317,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 1410,
                    "end": 1412,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                }
            ],
            "section": "Diagnosis of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "Molecular typing is not routinely performed on AdV-positive clinical specimens in clinical diagnostic laboratories but has been the focus of several recently reported studies investigating the epidemiology of AdV-associated disease. Serological tests may be useful in epidemiological investigations, but are of limited practical value in individual patients.38 Determination of serotype by seroneutralization with reference sera is laborious and time-consuming and currently only performed at a few reference public health laboratories around the world. PCR-based techniques targeting the fiber genes233 or hypervariable regions of the hexon235\n298 and/or sequencing of hexon genes allow definitive identification of the type/species.29\n31 Molecular typing by PCR amplification and sequencing of both hexon and fiber genes has proved to be extremely valuable for the identification of intertypic recombinants.299\n300\n",
            "cite_spans": [
                {
                    "start": 358,
                    "end": 360,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 600,
                    "end": 603,
                    "mention": "233",
                    "ref_id": "BIBREF150"
                },
                {
                    "start": 641,
                    "end": 644,
                    "mention": "235",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 645,
                    "end": 648,
                    "mention": "298",
                    "ref_id": "BIBREF221"
                },
                {
                    "start": 734,
                    "end": 736,
                    "mention": "29",
                    "ref_id": "BIBREF212"
                },
                {
                    "start": 737,
                    "end": 739,
                    "mention": "31",
                    "ref_id": "BIBREF235"
                },
                {
                    "start": 909,
                    "end": 912,
                    "mention": "299",
                    "ref_id": "BIBREF222"
                },
                {
                    "start": 913,
                    "end": 916,
                    "mention": "300",
                    "ref_id": "BIBREF225"
                }
            ],
            "section": "Diagnosis of Adenovirus Infection",
            "ref_spans": []
        },
        {
            "text": "No antiviral drug has been approved to treat AdV.38 Prospective randomized controlled trials are lacking.14 CDV, a cytosine nucleotide analogue that inhibits DNA polymerase, has the greatest in vitro activity against AdV among currently available antiviral agents301\n302\n303 and is the preferred therapeutic agent.2 CDV is available only intravenously.2 Regimens (dosing, frequency, and duration) are variable. Standard doses include 5 mg/kg every 1 to 2 weeks38\n188 or 1 mg/kg twice weekly.38\n158\n188 Duration of therapy is variable (weeks to months) and depends upon clinical response and persistence or eradication of AdV.158\n188 CDV is generally well tolerated,153\n188\n304 but adverse effects include nephrotoxicity, myelosuppression, and uveitis.2\n38 Hydration and probenecid may minimize nephrotoxicity.2\n143\n153\n201\n209 Careful monitoring of renal function (serum creatinine, proteinuria) is critical. Hexadecyloxy propyl-CDV or brincidofovir (CMX001), an orally active lipophilic form of CDV, has potent activity against AdV in vitro305 and in animal models,306\n307 with anecdotal successes in small clinical series.308\n309 Compared with CDV, CMX001 appears be less nephrotoxic.310 An open-label phase 3 trial to assess safety and efficacy of CMX001 for treating AdV infections in immunosuppressed patients is in progress (Clinical Trials.gov identifier: NCT02087306).",
            "cite_spans": [
                {
                    "start": 49,
                    "end": 51,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 105,
                    "end": 107,
                    "mention": "14",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 263,
                    "end": 266,
                    "mention": "301",
                    "ref_id": "BIBREF226"
                },
                {
                    "start": 267,
                    "end": 270,
                    "mention": "302",
                    "ref_id": "BIBREF227"
                },
                {
                    "start": 271,
                    "end": 274,
                    "mention": "303",
                    "ref_id": "BIBREF228"
                },
                {
                    "start": 314,
                    "end": 315,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 352,
                    "end": 353,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 460,
                    "end": 462,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 463,
                    "end": 466,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 491,
                    "end": 493,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 494,
                    "end": 497,
                    "mention": "158",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 498,
                    "end": 501,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 625,
                    "end": 628,
                    "mention": "158",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 629,
                    "end": 632,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 665,
                    "end": 668,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 669,
                    "end": 672,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 673,
                    "end": 676,
                    "mention": "304",
                    "ref_id": "BIBREF229"
                },
                {
                    "start": 751,
                    "end": 752,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 753,
                    "end": 755,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 809,
                    "end": 810,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 811,
                    "end": 814,
                    "mention": "143",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 815,
                    "end": 818,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 819,
                    "end": 822,
                    "mention": "201",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 823,
                    "end": 826,
                    "mention": "209",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 1041,
                    "end": 1044,
                    "mention": "305",
                    "ref_id": "BIBREF230"
                },
                {
                    "start": 1066,
                    "end": 1069,
                    "mention": "306",
                    "ref_id": "BIBREF231"
                },
                {
                    "start": 1070,
                    "end": 1073,
                    "mention": "307",
                    "ref_id": "BIBREF232"
                },
                {
                    "start": 1124,
                    "end": 1127,
                    "mention": "308",
                    "ref_id": "BIBREF233"
                },
                {
                    "start": 1128,
                    "end": 1131,
                    "mention": "309",
                    "ref_id": "BIBREF234"
                },
                {
                    "start": 1186,
                    "end": 1189,
                    "mention": "310",
                    "ref_id": "BIBREF236"
                }
            ],
            "section": "Therapy",
            "ref_spans": []
        },
        {
            "text": "Numerous nonrandomized studies in HSCT and SOT recipients documented favorable responses to CDV.25\n26\n28\n153\n158\n188\n192\n209\n231\n311\n312\n313\n314\n315\n316\n317 Three studies of allogeneic HSCT recipients with AdV infections cited improvement with CDV in 20/29 (69%),311 10/14 (77%),318 and 8/10 (80%) patients, respectively.192 However, given the lack of controlled trials, indications for, and efficacy of CDV remain controversial.27 Interpretation of these studies is confounded by heterogeneous patient populations, differing extent and sites of disease, and degree of immunosuppression or immune reconstitution.38 Intravenous immunoglobulin has been used (together with CDV), but data are insufficient to assess efficacy.25\n316\n",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 98,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 99,
                    "end": 101,
                    "mention": "26",
                    "ref_id": "BIBREF179"
                },
                {
                    "start": 102,
                    "end": 104,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 105,
                    "end": 108,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 109,
                    "end": 112,
                    "mention": "158",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 113,
                    "end": 116,
                    "mention": "188",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 117,
                    "end": 120,
                    "mention": "192",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 121,
                    "end": 124,
                    "mention": "209",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 125,
                    "end": 128,
                    "mention": "231",
                    "ref_id": "BIBREF148"
                },
                {
                    "start": 129,
                    "end": 132,
                    "mention": "311",
                    "ref_id": "BIBREF237"
                },
                {
                    "start": 133,
                    "end": 136,
                    "mention": "312",
                    "ref_id": "BIBREF238"
                },
                {
                    "start": 137,
                    "end": 140,
                    "mention": "313",
                    "ref_id": "BIBREF239"
                },
                {
                    "start": 141,
                    "end": 144,
                    "mention": "314",
                    "ref_id": "BIBREF240"
                },
                {
                    "start": 145,
                    "end": 148,
                    "mention": "315",
                    "ref_id": "BIBREF241"
                },
                {
                    "start": 149,
                    "end": 152,
                    "mention": "316",
                    "ref_id": "BIBREF242"
                },
                {
                    "start": 153,
                    "end": 156,
                    "mention": "317",
                    "ref_id": "BIBREF243"
                },
                {
                    "start": 263,
                    "end": 266,
                    "mention": "311",
                    "ref_id": "BIBREF237"
                },
                {
                    "start": 279,
                    "end": 282,
                    "mention": "318",
                    "ref_id": "BIBREF244"
                },
                {
                    "start": 321,
                    "end": 324,
                    "mention": "192",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 429,
                    "end": 431,
                    "mention": "27",
                    "ref_id": "BIBREF190"
                },
                {
                    "start": 612,
                    "end": 614,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 722,
                    "end": 724,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 725,
                    "end": 728,
                    "mention": "316",
                    "ref_id": "BIBREF242"
                }
            ],
            "section": "Therapy",
            "ref_spans": []
        },
        {
            "text": "Immune reconstitution plays a critical role in controlling AdV infection.38 Increases in lymphocyte counts or CD4 counts were associated with clearance of AdV infection319\n320 and improved survival.320\n321 Serotypic-specific neutralizing antibodies correlate with clearance of AdV.38\n320 Reduction of immunosuppression,146\n153 immune reconstitution of HSCT recipients,25\n38 or donor leukocyte infusions28 may have adjunctive roles to treat serious or recalcitrant AdV infections. T cells are important to eradicate AdV. Adoptive transfer of AdV antigen-specific T cells may reconstitute immunity against AdV.322\n323 In a recent clinical trial of HSCT recipients with AdV disease refractory to therapy, ex vivo adoptive T-cell transfer with predominantly TH-1 phenotype was highly effective in clearing viremia and markedly reduced mortality.324\n",
            "cite_spans": [
                {
                    "start": 73,
                    "end": 75,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 168,
                    "end": 171,
                    "mention": "319",
                    "ref_id": "BIBREF245"
                },
                {
                    "start": 172,
                    "end": 175,
                    "mention": "320",
                    "ref_id": "BIBREF247"
                },
                {
                    "start": 198,
                    "end": 201,
                    "mention": "320",
                    "ref_id": "BIBREF247"
                },
                {
                    "start": 202,
                    "end": 205,
                    "mention": "321",
                    "ref_id": "BIBREF248"
                },
                {
                    "start": 281,
                    "end": 283,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 284,
                    "end": 287,
                    "mention": "320",
                    "ref_id": "BIBREF247"
                },
                {
                    "start": 319,
                    "end": 322,
                    "mention": "146",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 323,
                    "end": 326,
                    "mention": "153",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 368,
                    "end": 370,
                    "mention": "25",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 371,
                    "end": 373,
                    "mention": "38",
                    "ref_id": "BIBREF258"
                },
                {
                    "start": 402,
                    "end": 404,
                    "mention": "28",
                    "ref_id": "BIBREF201"
                },
                {
                    "start": 608,
                    "end": 611,
                    "mention": "322",
                    "ref_id": "BIBREF249"
                },
                {
                    "start": 612,
                    "end": 615,
                    "mention": "323",
                    "ref_id": "BIBREF250"
                },
                {
                    "start": 841,
                    "end": 844,
                    "mention": "324",
                    "ref_id": "BIBREF251"
                }
            ],
            "section": "Therapy",
            "ref_spans": []
        },
        {
            "text": "Importantly, not all patients with AdV infections or viremia require treatment.2\n14\n43\n201 High-mortality rates in retrospective studies in part reflect that virtually all patients had symptomatic AdV infections. Prospective studies in SOT196 or HSCT43 recipients using plasma PCR at regular intervals noted that up to 58% were asymptomatic at the time of viremia, and spontaneous resolution without sequela was common. In a cohort of SOT recipients with AdV viremia, all 19 recovered spontaneously without sequela.196 Similarly, in a cohort of 26 pediatric HSCT recipients, 11 (42%) developed AdV viremia that cleared without therapy in 7 (64%).43 Two children died as a result of AdV infections. Antiviral treatment should be considered for the following indications: disseminated (\u2265 2 sites) disease; pneumonia; high viral loads in blood; virulence or tropism of the viral strain; persistent severe lymphopenia or immune deficits. Further, \u201cpreemptive\u201d therapy may have a role in viremic but asymptomatic organ transplant recipients at high risk for dissemination. Prospective, randomized trials are needed to elucidate indications for therapy in both symptomatic and asymptomatic patients with AdV infections.",
            "cite_spans": [
                {
                    "start": 79,
                    "end": 80,
                    "mention": "2",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 81,
                    "end": 83,
                    "mention": "14",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 84,
                    "end": 86,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 87,
                    "end": 90,
                    "mention": "201",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 239,
                    "end": 242,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 250,
                    "end": 252,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                },
                {
                    "start": 515,
                    "end": 518,
                    "mention": "196",
                    "ref_id": "BIBREF110"
                },
                {
                    "start": 646,
                    "end": 648,
                    "mention": "43",
                    "ref_id": "BIBREF264"
                }
            ],
            "section": "Therapy",
            "ref_spans": []
        },
        {
            "text": "Oral vaccines against AdV types 4 and 7 developed for the U. S. military in 197120 were depleted by 1999.20 Produced by a new manufacturer, and after a new round of clinical trials179 the same live nonattenuated vaccine formulation for AdV-4 and -7 was successfully reintroduced for military use in the United States in October 2011.39 Importantly, antibodies to AdV-4 and -7 may cross protect against other serotypes (e.g., AdV-3 and -14).86\n274\n325\n",
            "cite_spans": [
                {
                    "start": 80,
                    "end": 82,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 105,
                    "end": 107,
                    "mention": "20",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 180,
                    "end": 183,
                    "mention": "179",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 333,
                    "end": 335,
                    "mention": "39",
                    "ref_id": "BIBREF259"
                },
                {
                    "start": 440,
                    "end": 442,
                    "mention": "86",
                    "ref_id": "BIBREF311"
                },
                {
                    "start": 443,
                    "end": 446,
                    "mention": "274",
                    "ref_id": "BIBREF195"
                },
                {
                    "start": 447,
                    "end": 450,
                    "mention": "325",
                    "ref_id": "BIBREF252"
                }
            ],
            "section": "Vaccines",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig. 1: \nFatal case of adenovirus pneumonia. (A) Gross lung with pale, consolidated region, C. (B) Histopathology showing hemorrhagic necrotic lung tissue (hematoxylin and eosin [H & E] stain \u00d740. (C) High magnification showing three cells with intranuclear inclusions (arrow) (H & E) stain \u00d7400. (D) Immunohistochemical staining for adenovirus showing positive staining of the intranuclear inclusions in two cells (arrow) (immunoperoxidase \u00d7400). (Reproduced with permission from Lynch et al.1)",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Adenovirus",
            "authors": [],
            "year": 2005,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1835-1841",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Adenoviruses",
            "authors": [],
            "year": 2007,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "2395-2436",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Adenoviruses",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1843-1856",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Adenovirus",
            "authors": [],
            "year": 2011,
            "venue": "Semin Respir Crit Care Med",
            "volume": "32",
            "issn": "4",
            "pages": "494-511",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Molecular epidemiology of human adenovirus isolated from children hospitalized with acute respiratory infection in S\u00e3o Paulo, Brazil",
            "authors": [],
            "year": 2007,
            "venue": "J Med Virol",
            "volume": "79",
            "issn": "2",
            "pages": "174-181",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Immunodetection of adenoviral E1A proteins in human lung tissue",
            "authors": [],
            "year": 1995,
            "venue": "Am J Respir Cell Mol Biol",
            "volume": "12",
            "issn": "6",
            "pages": "642-648",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Latent adenoviral infection in the pathogenesis of chronic airways obstruction",
            "authors": [],
            "year": 1992,
            "venue": "Am Rev Respir Dis",
            "volume": "146",
            "issn": "1",
            "pages": "177-184",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a Neonatal Intensive Care Unit",
            "authors": [],
            "year": 2003,
            "venue": "J Clin Virol",
            "volume": "28",
            "issn": "3",
            "pages": "257-264",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Nosocomial outbreak of epidemic keratoconjunctivitis accompanying environmental contamination with adenoviruses",
            "authors": [],
            "year": 2008,
            "venue": "J Hosp Infect",
            "volume": "68",
            "issn": "3",
            "pages": "262-268",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis",
            "authors": [],
            "year": 2008,
            "venue": "J Clin Microbiol",
            "volume": "46",
            "issn": "6",
            "pages": "2002-2008",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia",
            "authors": [],
            "year": 2010,
            "venue": "Mol Vis",
            "volume": "16",
            "issn": "",
            "pages": "2132-2136",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan",
            "authors": [],
            "year": 2002,
            "venue": "Int Ophthalmol Clin",
            "volume": "42",
            "issn": "1",
            "pages": "49-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "The change of etiological agents and clinical signs of epidemic viral conjunctivitis over an 18-year period in southern Taiwan",
            "authors": [],
            "year": 2003,
            "venue": "Graefes Arch Clin Exp Ophthalmol",
            "volume": "241",
            "issn": "7",
            "pages": "554-560",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Isolation and identification of adenovirus from conjunctival scrapings over a two-year period (between 2001 and 2003) in Yokohama, Japan",
            "authors": [],
            "year": 2007,
            "venue": "J Med Virol",
            "volume": "79",
            "issn": "2",
            "pages": "200-205",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Molecular epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam",
            "authors": [],
            "year": 2006,
            "venue": "Am J Ophthalmol",
            "volume": "142",
            "issn": "6",
            "pages": "1064-1066",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "A two decade survey of respiratory adenovirus in Taiwan: the reemergence of adenovirus types 7 and 4",
            "authors": [],
            "year": 2004,
            "venue": "J Med Virol",
            "volume": "73",
            "issn": "2",
            "pages": "274-279",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years",
            "authors": [],
            "year": 2005,
            "venue": "J Clin Microbiol",
            "volume": "43",
            "issn": "2",
            "pages": "726-732",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Human adenovirus type 8 epidemic keratoconjunctivitis with large corneal epithelial full-layer detachment: an endemic outbreak with uncommon manifestations",
            "authors": [],
            "year": 2015,
            "venue": "Clin Ophthalmol",
            "volume": "9",
            "issn": "",
            "pages": "953-957",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Adenovirus-associated epidemic keratoconjunctivitis outbreaks\u2014four states, 2008-2010",
            "authors": [],
            "year": 2013,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "62",
            "issn": "32",
            "pages": "637-641",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Analysis with restriction endonucleases recognizing 4- or 5-base-pair sequences of human adenovirus type 3 isolated from ocular diseases in Sapporo, Japan",
            "authors": [],
            "year": 1990,
            "venue": "J Clin Microbiol",
            "volume": "28",
            "issn": "10",
            "pages": "2365-2369",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in Japan",
            "authors": [],
            "year": 2004,
            "venue": "J Clin Microbiol",
            "volume": "42",
            "issn": "8",
            "pages": "3644-3648",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Epidemic keratoconjunctivitis outbreak at a tertiary referral eye care clinic",
            "authors": [],
            "year": 1998,
            "venue": "Am J Infect Control",
            "volume": "26",
            "issn": "4",
            "pages": "399-405",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "An outbreak of adenovirus type 8 keratoconjunctivitis in a nursing home in Madrid",
            "authors": [],
            "year": 2004,
            "venue": "Euro Surveill",
            "volume": "9",
            "issn": "3",
            "pages": "27-30",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Ten years' surveillance of viral conjunctivitis in Sapporo, Japan",
            "authors": [],
            "year": 1999,
            "venue": "Graefes Arch Clin Exp Ophthalmol",
            "volume": "237",
            "issn": "1",
            "pages": "35-38",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Detection and prevalence of adenoviral conjunctivitis among hospital employees using real-time polymerase chain reaction as an infection prevention tool",
            "authors": [],
            "year": 2014,
            "venue": "Infect Control Hosp Epidemiol",
            "volume": "35",
            "issn": "6",
            "pages": "728-731",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Recombination analysis of intermediate human adenovirus type 53 in Japan by complete genome sequence",
            "authors": [],
            "year": 2011,
            "venue": "J Gen Virol",
            "volume": "92",
            "issn": "Pt 6",
            "pages": "1251-1259",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Molecular epidemiology of adenovirus types 3 and 7 isolated from children with pneumonia in Beijing",
            "authors": [],
            "year": 1996,
            "venue": "J Med Virol",
            "volume": "49",
            "issn": "3",
            "pages": "170-177",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Outbreak of epidemic keratoconjunctivitis caused by human adenovirus type 56, China, 2012",
            "authors": [],
            "year": 2014,
            "venue": "PLoS ONE",
            "volume": "9",
            "issn": "10",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Isolation of an intertypic recombinant human adenovirus (candidate type 56) from the pharyngeal swab of a patient with pharyngoconjunctival fever",
            "authors": [],
            "year": 2012,
            "venue": "Jpn J Infect Dis",
            "volume": "65",
            "issn": "5",
            "pages": "457-459",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis",
            "authors": [],
            "year": 2009,
            "venue": "PLoS ONE",
            "volume": "4",
            "issn": "6",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan",
            "authors": [],
            "year": 2011,
            "venue": "Br J Ophthalmol",
            "volume": "95",
            "issn": "1",
            "pages": "32-36",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Molecular epidemiology of human adenoviruses d associated with epidemic keratoconjunctivitis in Osaka, Japan, 2001-2010",
            "authors": [],
            "year": 2013,
            "venue": "Jpn J Infect Dis",
            "volume": "66",
            "issn": "5",
            "pages": "436-438",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Prevalence and molecular characterisation of human adenovirus in diarrhoeic children in Tanzania; a case control study",
            "authors": [],
            "year": 2014,
            "venue": "BMC Infect Dis",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation",
            "authors": [],
            "year": 1995,
            "venue": "J Pediatr Gastroenterol Nutr",
            "volume": "21",
            "issn": "1",
            "pages": "110-112",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Adenovirus colitis in the acquired immunodeficiency syndrome",
            "authors": [],
            "year": 1991,
            "venue": "Gastroenterology",
            "volume": "100",
            "issn": "4",
            "pages": "976-979",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature",
            "authors": [],
            "year": 2003,
            "venue": "Arch Pathol Lab Med",
            "volume": "127",
            "issn": "5",
            "pages": "e246-e248",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient",
            "authors": [],
            "year": 2000,
            "venue": "Pediatr Infect Dis J",
            "volume": "19",
            "issn": "11",
            "pages": "1097-1100",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Respiratory adenoviral infections in children: a study of hospitalized cases in southern Taiwan in 2001\u20132002",
            "authors": [],
            "year": 2004,
            "venue": "J Trop Pediatr",
            "volume": "50",
            "issn": "5",
            "pages": "279-284",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Adenovirus hepatitis presenting as tumoral lesions in an immunocompromised patient",
            "authors": [],
            "year": 2014,
            "venue": "Ann Hepatol",
            "volume": "13",
            "issn": "6",
            "pages": "827-829",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Adenovirus colitis in human immunodeficiency virus infection: an underdiagnosed entity",
            "authors": [],
            "year": 1998,
            "venue": "Am J Surg Pathol",
            "volume": "22",
            "issn": "9",
            "pages": "1101-1106",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Adenovirus cholecystitis in a patient with AIDS",
            "authors": [],
            "year": 1998,
            "venue": "Clin Infect Dis",
            "volume": "26",
            "issn": "4",
            "pages": "997-999",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Pancreatitis and adenoviral infection in children after blood and marrow transplantation",
            "authors": [],
            "year": 2006,
            "venue": "Bone Marrow Transplant",
            "volume": "38",
            "issn": "12",
            "pages": "807-811",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Acute pancreatitis after severe opthalmic adenoviral infection",
            "authors": [],
            "year": 2011,
            "venue": "Acta Gastroenterol Belg",
            "volume": "74",
            "issn": "2",
            "pages": "361-362",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Adenovirus-associated hemorrhagic cystitis in a patient with plasma cell myeloma treated with bortezomib",
            "authors": [],
            "year": 2009,
            "venue": "Leuk Res",
            "volume": "33",
            "issn": "8",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation",
            "authors": [],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "9",
            "pages": "1325-1330",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine",
            "authors": [],
            "year": 2004,
            "venue": "Bone Marrow Transplant",
            "volume": "33",
            "issn": "1",
            "pages": "87-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors",
            "authors": [],
            "year": 2000,
            "venue": "Bone Marrow Transplant",
            "volume": "25",
            "issn": "5",
            "pages": "545-548",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient",
            "authors": [],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "40",
            "issn": "1",
            "pages": "199-201",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)",
            "authors": [],
            "year": 2012,
            "venue": "Transpl Infect Dis",
            "volume": "14",
            "issn": "6",
            "pages": "555-563",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Hemorrhagic adenovirus cystitis after renal transplantation",
            "authors": [],
            "year": 2004,
            "venue": "Transplant Proc",
            "volume": "36",
            "issn": "10",
            "pages": "3025-3027",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "Hemorrhagic cystitis secondary to adenovirus or herpes simplex virus infection following renal transplantation: four case reports",
            "authors": [],
            "year": 2009,
            "venue": "Transplant Proc",
            "volume": "41",
            "issn": "10",
            "pages": "4416-4419",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation",
            "authors": [],
            "year": 1995,
            "venue": "Urol Int",
            "volume": "54",
            "issn": "3",
            "pages": "142-146",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient",
            "authors": [],
            "year": 2007,
            "venue": "Pediatr Transplant",
            "volume": "11",
            "issn": "5",
            "pages": "568-571",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "Acute hemorrhagic cystitis caused by adenovirus following renal transplantation: review of the literature",
            "authors": [],
            "year": 1993,
            "venue": "J Urol",
            "volume": "149",
            "issn": "4",
            "pages": "838-839",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia",
            "authors": [],
            "year": 2014,
            "venue": "Transpl Infect Dis",
            "volume": "16",
            "issn": "4",
            "pages": "648-652",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient",
            "authors": [],
            "year": 2011,
            "venue": "Transpl Infect Dis",
            "volume": "13",
            "issn": "2",
            "pages": "174-177",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Adenovirus nephritis in hematopoietic stem-cell transplantation",
            "authors": [],
            "year": 2004,
            "venue": "Transplantation",
            "volume": "77",
            "issn": "7",
            "pages": "1049-1057",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Necrotizing tubulointerstitial nephritis associated with adenovirus infection",
            "authors": [],
            "year": 1991,
            "venue": "Hum Pathol",
            "volume": "22",
            "issn": "12",
            "pages": "1225-1231",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "Fatal disseminated adenoviral infection in a renal transplant patient",
            "authors": [],
            "year": 2001,
            "venue": "Transplantation",
            "volume": "71",
            "issn": "7",
            "pages": "998-999",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients",
            "authors": [],
            "year": 2012,
            "venue": "Mol Diagn Ther",
            "volume": "16",
            "issn": "2",
            "pages": "63-77",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Prediction of severe disseminated adenovirus infection by serum PCR",
            "authors": [],
            "year": 2001,
            "venue": "Lancet",
            "volume": "358",
            "issn": "9279",
            "pages": "384-385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "Acute renal failure due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient",
            "authors": [],
            "year": 2003,
            "venue": "Bone Marrow Transplant",
            "volume": "31",
            "issn": "12",
            "pages": "1173-1176",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Adenovirus urethritis and concurrent conjunctivitis: a case series and review of the literature",
            "authors": [],
            "year": 2015,
            "venue": "Sex Transm Infect",
            "volume": "91",
            "issn": "2",
            "pages": "87-90",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention",
            "authors": [],
            "year": 2007,
            "venue": "J Pediatr Hematol Oncol",
            "volume": "29",
            "issn": "2",
            "pages": "81-85",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome",
            "authors": [],
            "year": 2007,
            "venue": "Haematologica",
            "volume": "92",
            "issn": "9",
            "pages": "1254-1257",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF65": {
            "title": "Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation",
            "authors": [],
            "year": 2007,
            "venue": "J Clin Virol",
            "volume": "38",
            "issn": "4",
            "pages": "341-347",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF66": {
            "title": "Adenoviral infections in pediatric transplant recipients: a hospital-based study",
            "authors": [],
            "year": 2006,
            "venue": "Pediatr Infect Dis J",
            "volume": "25",
            "issn": "9",
            "pages": "815-818",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved",
            "authors": [],
            "year": 2000,
            "venue": "J Hosp Infect",
            "volume": "44",
            "issn": "1",
            "pages": "71-74",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF68": {
            "title": "Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation",
            "authors": [],
            "year": 2001,
            "venue": "Biol Blood Marrow Transplant",
            "volume": "7",
            "issn": "7",
            "pages": "388-394",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "Adenovirus meningoencephalitis",
            "authors": [],
            "year": 1978,
            "venue": "Pediatrics",
            "volume": "61",
            "issn": "2",
            "pages": "291-293",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF70": {
            "title": "Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies",
            "authors": [],
            "year": 2002,
            "venue": "Clin Infect Dis",
            "volume": "35",
            "issn": "7",
            "pages": "808-818",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Extrapulmonary manifestations of adenovirus type 7 pneumonia simulating Reye syndrome and the possible role of an adenovirus toxin",
            "authors": [],
            "year": 1979,
            "venue": "J Pediatr",
            "volume": "95",
            "issn": "3",
            "pages": "348-355",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF72": {
            "title": "Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006",
            "authors": [],
            "year": 2007,
            "venue": "Clin Infect Dis",
            "volume": "45",
            "issn": "9",
            "pages": "1120-1131",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF73": {
            "title": "Adenovirus infection associated with central nervous system dysfunction in children",
            "authors": [],
            "year": 2013,
            "venue": "J Clin Virol",
            "volume": "57",
            "issn": "4",
            "pages": "300-304",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Acute meningoencephalitis caused by adenovirus serotype 26",
            "authors": [],
            "year": 2006,
            "venue": "J Neurovirol",
            "volume": "12",
            "issn": "3",
            "pages": "235-240",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "Meningoencephalitis due to adenovirus in a healthy infant mimicking severe bacterial sepsis",
            "authors": [],
            "year": 2014,
            "venue": "Pediatr Infect Dis J",
            "volume": "33",
            "issn": "4",
            "pages": "416-419",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation",
            "authors": [],
            "year": 2011,
            "venue": "J Clin Microbiol",
            "volume": "49",
            "issn": "6",
            "pages": "2361-2364",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF77": {
            "title": "Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults",
            "authors": [],
            "year": 2003,
            "venue": "J Am Coll Cardiol",
            "volume": "42",
            "issn": "3",
            "pages": "466-472",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "First report on fatal myocarditis associated with adenovirus infection in Cuba",
            "authors": [],
            "year": 2008,
            "venue": "J Med Virol",
            "volume": "80",
            "issn": "10",
            "pages": "1756-1761",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF79": {
            "title": "Involvement of adenovirus in clinical mononucleosis-like syndromes in young children",
            "authors": [],
            "year": 2005,
            "venue": "Eur J Clin Microbiol Infect Dis",
            "volume": "24",
            "issn": "5",
            "pages": "314-318",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF80": {
            "title": "Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia",
            "authors": [],
            "year": 2000,
            "venue": "Pediatr Res",
            "volume": "47",
            "issn": "2",
            "pages": "225-232",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF81": {
            "title": "Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults",
            "authors": [],
            "year": 2001,
            "venue": "J Med Virol",
            "volume": "65",
            "issn": "4",
            "pages": "710-718",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF82": {
            "title": "Intestinal intussusception associated with adenovirus infection in Mexican children",
            "authors": [],
            "year": 2003,
            "venue": "Am J Clin Pathol",
            "volume": "120",
            "issn": "6",
            "pages": "845-850",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF83": {
            "title": "Detection and significance of adenoviruses in cases of sudden infant death",
            "authors": [],
            "year": 1996,
            "venue": "Virchows Arch",
            "volume": "428",
            "issn": "2",
            "pages": "113-118",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF84": {
            "title": "Respiratory syncytial virus, adenoviruses, and mixed acute lower respiratory infections in children in a developing country",
            "authors": [],
            "year": 2015,
            "venue": "J Med Virol",
            "volume": "87",
            "issn": "5",
            "pages": "774-781",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF85": {
            "title": "Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial",
            "authors": [],
            "year": 2015,
            "venue": "Vaccine",
            "volume": "33",
            "issn": "9",
            "pages": "1182-1187",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF86": {
            "title": "Control of adenovirus acute respiratory disease in U.S. Army trainees",
            "authors": [],
            "year": 1975,
            "venue": "Yale J Biol Med",
            "volume": "48",
            "issn": "3",
            "pages": "185-195",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF87": {
            "title": "Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines",
            "authors": [],
            "year": 2014,
            "venue": "Clin Infect Dis",
            "volume": "59",
            "issn": "7",
            "pages": "962-968",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF88": {
            "title": "Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination",
            "authors": [],
            "year": 1999,
            "venue": "J Infect Dis",
            "volume": "179",
            "issn": "6",
            "pages": "1531-1533",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF89": {
            "title": "Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees",
            "authors": [],
            "year": 1999,
            "venue": "Emerg Infect Dis",
            "volume": "5",
            "issn": "6",
            "pages": "798-801",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF90": {
            "title": "Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics",
            "authors": [],
            "year": 2000,
            "venue": "Clin Infect Dis",
            "volume": "31",
            "issn": "3",
            "pages": "663-670",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF91": {
            "title": "A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits",
            "authors": [],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "28",
            "pages": "2963-2971",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF92": {
            "title": "Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003)",
            "authors": [],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "196",
            "issn": "1",
            "pages": "67-75",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF93": {
            "title": "Adenovirus as an emerging pathogen in immunocompromised patients",
            "authors": [],
            "year": 2005,
            "venue": "Br J Haematol",
            "volume": "128",
            "issn": "2",
            "pages": "135-144",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF94": {
            "title": "Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation",
            "authors": [],
            "year": 2000,
            "venue": "Bone Marrow Transplant",
            "volume": "26",
            "issn": "12",
            "pages": "1333-1338",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF95": {
            "title": "Adenovirus infections in adult recipients of blood and marrow transplants",
            "authors": [],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "6",
            "pages": "871-876",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF96": {
            "title": "Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality",
            "authors": [],
            "year": 2012,
            "venue": "Br J Haematol",
            "volume": "156",
            "issn": "1",
            "pages": "99-108",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF97": {
            "title": "Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients",
            "authors": [],
            "year": 2010,
            "venue": "Adv Hematol",
            "volume": "2010",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF98": {
            "title": "Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)",
            "authors": [],
            "year": 2009,
            "venue": "Mol Immunol",
            "volume": "47",
            "issn": "1",
            "pages": "46-51",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF99": {
            "title": "Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases",
            "authors": [],
            "year": 2009,
            "venue": "Transpl Infect Dis",
            "volume": "11",
            "issn": "4",
            "pages": "318-323",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF100": {
            "title": "Low incidence of adenovirus hemorrhagic cystitis following autologous hematopoietic stem cell transplantation in the rituximab era",
            "authors": [],
            "year": 2012,
            "venue": "Am J Hematol",
            "volume": "87",
            "issn": "8",
            "pages": "828-830",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF101": {
            "title": "Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients",
            "authors": [],
            "year": 2006,
            "venue": "Transplantation",
            "volume": "81",
            "issn": "10",
            "pages": "1398-1404",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF102": {
            "title": "Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection",
            "authors": [],
            "year": 2004,
            "venue": "Clin Infect Dis",
            "volume": "38",
            "issn": "1",
            "pages": "45-52",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF103": {
            "title": "Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults",
            "authors": [],
            "year": 2002,
            "venue": "Clin Infect Dis",
            "volume": "34",
            "issn": "5",
            "pages": "577-582",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF104": {
            "title": "Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study",
            "authors": [],
            "year": 2001,
            "venue": "Bone Marrow Transplant",
            "volume": "28",
            "issn": "1",
            "pages": "51-57",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF105": {
            "title": "Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution",
            "authors": [],
            "year": 2013,
            "venue": "Biol Blood Marrow Transplant",
            "volume": "19",
            "issn": "3",
            "pages": "387-392",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF106": {
            "title": "Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients",
            "authors": [],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "41",
            "issn": "12",
            "pages": "1812-1816",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF107": {
            "title": "Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults",
            "authors": [],
            "year": 2012,
            "venue": "Clin Infect Dis",
            "volume": "55",
            "issn": "10",
            "pages": "1362-1370",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF108": {
            "title": "Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients",
            "authors": [],
            "year": 2002,
            "venue": "Clin Infect Dis",
            "volume": "34",
            "issn": "6",
            "pages": "864-867",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF109": {
            "title": "High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation",
            "authors": [],
            "year": 2002,
            "venue": "Clin Infect Dis",
            "volume": "35",
            "issn": "5",
            "pages": "526-532",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF110": {
            "title": "A surveillance study of adenovirus infection in adult solid organ transplant recipients",
            "authors": [],
            "year": 2005,
            "venue": "Am J Transplant",
            "volume": "5",
            "issn": "10",
            "pages": "2555-2559",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF111": {
            "title": "Adenoviruses in the immunocompromised host",
            "authors": [],
            "year": 1992,
            "venue": "Clin Microbiol Rev",
            "volume": "5",
            "issn": "3",
            "pages": "262-274",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF112": {
            "title": "Adenovirus infection in pediatric liver transplant recipients",
            "authors": [],
            "year": 1992,
            "venue": "J Infect Dis",
            "volume": "165",
            "issn": "1",
            "pages": "170-174",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF113": {
            "title": "Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance",
            "authors": [],
            "year": 1998,
            "venue": "J Infect Dis",
            "volume": "177",
            "issn": "2",
            "pages": "459-462",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF114": {
            "title": "Adenovirus infections in transplant recipients",
            "authors": [],
            "year": 2006,
            "venue": "Clin Infect Dis",
            "volume": "43",
            "issn": "3",
            "pages": "331-339",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF115": {
            "title": "Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004",
            "authors": [],
            "year": 2006,
            "venue": "Vaccine",
            "volume": "24",
            "issn": "15",
            "pages": "2835-2842",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF116": {
            "title": "Adenovirus infection in the lung results in graft failure after lung transplantation",
            "authors": [],
            "year": 1998,
            "venue": "J Thorac Cardiovasc Surg",
            "volume": "116",
            "issn": "4",
            "pages": "617-623",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF117": {
            "title": "What do we know about adenovirus in renal transplantation?",
            "authors": [],
            "year": 2013,
            "venue": "Nephrol Dial Transplant",
            "volume": "28",
            "issn": "8",
            "pages": "2003-2010",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF118": {
            "title": "Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery",
            "authors": [],
            "year": 2011,
            "venue": "Am J Transplant",
            "volume": "11",
            "issn": "6",
            "pages": "1308-1314",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF119": {
            "title": "Adenovirus infections in heart transplantation",
            "authors": [],
            "year": 2013,
            "venue": "Cardiol Rev",
            "volume": "21",
            "issn": "4",
            "pages": "203-206",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF120": {
            "title": "Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis",
            "authors": [],
            "year": 2015,
            "venue": "Transpl Infect Dis",
            "volume": "17",
            "issn": "1",
            "pages": "125-128",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF121": {
            "title": "Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR",
            "authors": [],
            "year": 2003,
            "venue": "Am J Transplant",
            "volume": "3",
            "issn": "2",
            "pages": "224-228",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF122": {
            "title": "Adenovirus infections in pediatric small bowel transplant recipients",
            "authors": [],
            "year": 2010,
            "venue": "Transplantation",
            "volume": "90",
            "issn": "2",
            "pages": "198-204",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF123": {
            "title": "Adenovirus pneumonia in lung transplant recipients",
            "authors": [],
            "year": 1995,
            "venue": "Hum Pathol",
            "volume": "26",
            "issn": "10",
            "pages": "1073-1079",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF124": {
            "title": "Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance",
            "authors": [],
            "year": 2006,
            "venue": "J Heart Lung Transplant",
            "volume": "25",
            "issn": "12",
            "pages": "1441-1446",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF125": {
            "title": "Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients",
            "authors": [],
            "year": 2007,
            "venue": "J Heart Lung Transplant",
            "volume": "26",
            "issn": "9",
            "pages": "883-889",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF126": {
            "title": "Civilian outbreak of adenovirus acute respiratory disease\u2014South Dakota, 1997",
            "authors": [],
            "year": 1998,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "47",
            "issn": "27",
            "pages": "567-570",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF127": {
            "title": "Adenovirus in solid organ transplantation",
            "authors": [],
            "year": 2013,
            "venue": "Am J Transplant",
            "volume": "13",
            "issn": "4",
            "pages": "206-211",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF128": {
            "title": "Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients",
            "authors": [],
            "year": 2010,
            "venue": "J Am Coll Cardiol",
            "volume": "56",
            "issn": "7",
            "pages": "582-592",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF129": {
            "title": "Association of viral genome with graft loss in children after cardiac transplantation",
            "authors": [],
            "year": 2001,
            "venue": "N Engl J Med",
            "volume": "344",
            "issn": "20",
            "pages": "1498-1503",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF130": {
            "title": "Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction",
            "authors": [],
            "year": 1996,
            "venue": "J Heart Lung Transplant",
            "volume": "15",
            "issn": "2",
            "pages": "111-123",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF131": {
            "title": "Late fatal adenovirus pneumonitis in a lung transplant recipient",
            "authors": [],
            "year": 1998,
            "venue": "Transplantation",
            "volume": "65",
            "issn": "4",
            "pages": "592-594",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF132": {
            "title": "Adenovirus viremia in human immunodeficiency virus-infected children",
            "authors": [],
            "year": 1997,
            "venue": "Pediatr Infect Dis J",
            "volume": "16",
            "issn": "4",
            "pages": "413-415",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF133": {
            "title": "Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology",
            "authors": [],
            "year": 1995,
            "venue": "J Infect Dis",
            "volume": "172",
            "issn": "3",
            "pages": "629-637",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF134": {
            "title": "Prevalence of adenovirus respiratory tract and hiv co-infections in patients attending the University of Ilorin, teaching hospital, Ilorin, Nigeria",
            "authors": [],
            "year": 2014,
            "venue": "BMC Res Notes",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF135": {
            "title": "Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome",
            "authors": [],
            "year": 1983,
            "venue": "Lancet",
            "volume": "1",
            "issn": "8337",
            "pages": "1293-1296",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF136": {
            "title": "X-linked agammaglobulinemia: report on a United States registry of 201 patients",
            "authors": [],
            "year": 2006,
            "venue": "Medicine (Baltimore)",
            "volume": "85",
            "issn": "4",
            "pages": "193-202",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF137": {
            "title": "Adenovirus pneumonia with severe sequelae in an immunocompetent adult",
            "authors": [],
            "year": 1992,
            "venue": "Clin Infect Dis",
            "volume": "15",
            "issn": "4",
            "pages": "712-713",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF138": {
            "title": "Acute respiratory disease associated with adenovirus serotype 14\u2014four states, 2006-2007",
            "authors": [],
            "year": 2007,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "56",
            "issn": "45",
            "pages": "1181-1184",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF139": {
            "title": "Outbreak of pneumonia associated with emergent human adenovirus serotype 14\u2014Southeast Alaska, 2008",
            "authors": [],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "202",
            "issn": "2",
            "pages": "214-222",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF140": {
            "title": "Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey",
            "authors": [],
            "year": 2005,
            "venue": "J Med Virol",
            "volume": "77",
            "issn": "2",
            "pages": "232-237",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF141": {
            "title": "Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991-1994)",
            "authors": [],
            "year": 1996,
            "venue": "J Med Virol",
            "volume": "48",
            "issn": "2",
            "pages": "151-156",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF142": {
            "title": "Adenovirus in solid organ transplant recipients",
            "authors": [],
            "year": 2009,
            "venue": "Am J Transplant",
            "volume": "9",
            "issn": "4",
            "pages": "S161-S165",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF143": {
            "title": "Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?",
            "authors": [],
            "year": 1999,
            "venue": "Br J Ophthalmol",
            "volume": "83",
            "issn": "5",
            "pages": "622-627",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF144": {
            "title": "Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children",
            "authors": [],
            "year": 1984,
            "venue": "J Clin Microbiol",
            "volume": "20",
            "issn": "3",
            "pages": "365-372",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF145": {
            "title": "Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management",
            "authors": [],
            "year": 2004,
            "venue": "Leuk Lymphoma",
            "volume": "45",
            "issn": "5",
            "pages": "873-885",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF146": {
            "title": "Fatal pneumonia associated with adenovirus type 7 in three military trainees",
            "authors": [],
            "year": 1972,
            "venue": "N Engl J Med",
            "volume": "286",
            "issn": "24",
            "pages": "1289-1292",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF147": {
            "title": "Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture",
            "authors": [],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "40",
            "issn": "5",
            "pages": "662-669",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF148": {
            "title": "Disseminated adenovirus infection with respiratory failure in pediatric liver transplant recipients: impact of intravenous cidofovir and inhaled nitric oxide",
            "authors": [],
            "year": 2006,
            "venue": "Pediatr Transplant",
            "volume": "10",
            "issn": "1",
            "pages": "121-127",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF149": {
            "title": "Adenovirus type 3 outbreak in connecticut associated with a novel variant",
            "authors": [],
            "year": 2009,
            "venue": "J Med Virol",
            "volume": "81",
            "issn": "8",
            "pages": "1380-1384",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF150": {
            "title": "Identification of subgenus C adenoviruses by fiber-based multiplex PCR",
            "authors": [],
            "year": 2004,
            "venue": "J Clin Microbiol",
            "volume": "42",
            "issn": "2",
            "pages": "670-673",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF151": {
            "title": "Assessment of genetic variability among subspecies b1 human adenoviruses for molecular epidemiology studies",
            "authors": [],
            "year": 2007,
            "venue": "Methods Mol Med",
            "volume": "131",
            "issn": "",
            "pages": "335-355",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF152": {
            "title": "Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay",
            "authors": [],
            "year": 2001,
            "venue": "J Med Virol",
            "volume": "64",
            "issn": "4",
            "pages": "537-542",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF153": {
            "title": "Analysis of 15 different genome types of adenovirus type 7 isolated on five continents",
            "authors": [],
            "year": 1986,
            "venue": "J Virol",
            "volume": "60",
            "issn": "1",
            "pages": "331-335",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF154": {
            "title": "Predicting the next eye pathogen: analysis of a novel adenovirus",
            "authors": [],
            "year": 2013,
            "venue": "MBio",
            "volume": "4",
            "issn": "2",
            "pages": "e00595-e12",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF155": {
            "title": "Molecular evolution of human species D adenoviruses",
            "authors": [],
            "year": 2011,
            "venue": "Infect Genet Evol",
            "volume": "11",
            "issn": "6",
            "pages": "1208-1217",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF156": {
            "title": "Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality",
            "authors": [],
            "year": 2011,
            "venue": "Virology",
            "volume": "409",
            "issn": "2",
            "pages": "141-147",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF157": {
            "title": "Severe pneumonia due to adenovirus serotype 14: a new respiratory threat?",
            "authors": [],
            "year": 2008,
            "venue": "Clin Infect Dis",
            "volume": "46",
            "issn": "3",
            "pages": "421-425",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF158": {
            "title": "Genome sequence of human adenovirus type 55, a re-emergent acute respiratory disease pathogen in China",
            "authors": [],
            "year": 2012,
            "venue": "J Virol",
            "volume": "86",
            "issn": "22",
            "pages": "12441-12442",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF159": {
            "title": "Using the whole-genome sequence to characterize and name human adenoviruses",
            "authors": [],
            "year": 2011,
            "venue": "J Virol",
            "volume": "85",
            "issn": "11",
            "pages": "5701-5702",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF160": {
            "title": "Trend of adenovirus type 7 infection, an emerging disease in Japan. A report of the National Epidemiological Surveillance of Infectious Agents in Japan",
            "authors": [],
            "year": 1998,
            "venue": "Jpn J Med Sci Biol",
            "volume": "51",
            "issn": "1",
            "pages": "43-51",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF161": {
            "title": "Molecular epidemiology of adenovirus type 7 in Israel: identification of two new genome types, Ad7k and Ad7d2",
            "authors": [],
            "year": 1998,
            "venue": "J Med Virol",
            "volume": "54",
            "issn": "4",
            "pages": "291-299",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF162": {
            "title": "Molecular epidemiology of adenoviruses: global distribution of adenovirus 7 genome types",
            "authors": [],
            "year": 1985,
            "venue": "J Clin Microbiol",
            "volume": "21",
            "issn": "3",
            "pages": "403-408",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF163": {
            "title": "PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections",
            "authors": [],
            "year": 2005,
            "venue": "J Clin Microbiol",
            "volume": "43",
            "issn": "11",
            "pages": "5743-5752",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF164": {
            "title": "Molecular epidemiology of adenoviruses associated with acute lower respiratory disease of children in Buenos Aires, Argentina (1984-1988)",
            "authors": [],
            "year": 1992,
            "venue": "J Med Virol",
            "volume": "36",
            "issn": "4",
            "pages": "292-297",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF165": {
            "title": "Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors",
            "authors": [],
            "year": 1998,
            "venue": "Pediatrics",
            "volume": "101",
            "issn": "6",
            "pages": "1013-1019",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF166": {
            "title": "The epidemiology of adenovirus infections in Greater Manchester, UK 1982-96",
            "authors": [],
            "year": 2000,
            "venue": "Epidemiol Infect",
            "volume": "125",
            "issn": "2",
            "pages": "333-345",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF167": {
            "title": "Genome type analysis of adenovirus types 3 and 7 isolated during successive outbreaks of lower respiratory tract infections in children",
            "authors": [],
            "year": 2003,
            "venue": "J Clin Microbiol",
            "volume": "41",
            "issn": "10",
            "pages": "4594-4599",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF168": {
            "title": "Treatment of adenovirus disease in stem cell transplant recipients with cidofovir",
            "authors": [],
            "year": 2007,
            "venue": "Biol Blood Marrow Transplant",
            "volume": "13",
            "issn": "1",
            "pages": "74-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF169": {
            "title": "Adenovirus type 7h respiratory infections: a report of 29 cases of acute lower respiratory disease",
            "authors": [],
            "year": 1993,
            "venue": "Acta Paediatr",
            "volume": "82",
            "issn": "6\u20137",
            "pages": "557-561",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF170": {
            "title": "Comparison of 17 genome types of adenovirus type 3 identified among strains recovered from six continents",
            "authors": [],
            "year": 1988,
            "venue": "J Clin Microbiol",
            "volume": "26",
            "issn": "5",
            "pages": "1009-1015",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF171": {
            "title": "Molecular epidemiology and restriction site mapping of adenovirus type 3 genome types",
            "authors": [],
            "year": 1989,
            "venue": "J Clin Microbiol",
            "volume": "27",
            "issn": "6",
            "pages": "1329-1334",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF172": {
            "title": "Outbreak of adenovirus type 1 severe pneumonia in a French intensive care unit, September-October 2012",
            "authors": [],
            "year": 2014,
            "venue": "Euro Surveill",
            "volume": "19",
            "issn": "39",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF173": {
            "title": "Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain",
            "authors": [],
            "year": 2010,
            "venue": "J Clin Microbiol",
            "volume": "48",
            "issn": "4",
            "pages": "1391-1396",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF174": {
            "title": "Outbreak of adenovirus type 4 infection in a long-term care facility for the elderly",
            "authors": [],
            "year": 2010,
            "venue": "Infect Control Hosp Epidemiol",
            "volume": "31",
            "issn": "7",
            "pages": "755-757",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF175": {
            "title": "Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7",
            "authors": [],
            "year": 1971,
            "venue": "J Infect Dis",
            "volume": "124",
            "issn": "2",
            "pages": "155-160",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF176": {
            "title": "Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans",
            "authors": [],
            "year": 1971,
            "venue": "J Infect Dis",
            "volume": "124",
            "issn": "2",
            "pages": "148-154",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF177": {
            "title": "Adenovirus type 7 peptide diversity during outbreak, Korea, 1995-2000",
            "authors": [],
            "year": 2005,
            "venue": "Emerg Infect Dis",
            "volume": "11",
            "issn": "5",
            "pages": "649-654",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF178": {
            "title": "Molecular and epidemiological analyses of human adenovirus type 7 strains isolated from the 1995 nationwide outbreak in Japan",
            "authors": [],
            "year": 2002,
            "venue": "J Clin Microbiol",
            "volume": "40",
            "issn": "1",
            "pages": "140-145",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF179": {
            "title": "Identification of adenoviruses in specimens from high-risk pediatric stem cell transplant recipients and controls",
            "authors": [],
            "year": 2008,
            "venue": "J Clin Microbiol",
            "volume": "46",
            "issn": "1",
            "pages": "317-320",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF180": {
            "title": "Pneumonia and massive pleural effusion associated with adenovirus type 7",
            "authors": [],
            "year": 1973,
            "venue": "Am J Dis Child",
            "volume": "126",
            "issn": "1",
            "pages": "92-94",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF181": {
            "title": "Impact of human adenovirus serotype 7 in hospitalized children with severe fatal pneumonia in the Philippines",
            "authors": [],
            "year": 2014,
            "venue": "Jpn J Infect Dis",
            "volume": "67",
            "issn": "2",
            "pages": "105-110",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF182": {
            "title": "Re-emergent human adenovirus genome type 7d caused an acute respiratory disease outbreak in Southern China after a twenty-one year absence",
            "authors": [],
            "year": 2014,
            "venue": "Sci Rep",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF183": {
            "title": "An outbreak of adenovirus type 7 infection in children in Montreal",
            "authors": [],
            "year": 1973,
            "venue": "Can Med Assoc J",
            "volume": "108",
            "issn": "4",
            "pages": "434-439",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF184": {
            "title": "Epidemic outbreaks of adenovirus 7 with special reference to the pathogenicity of adenovirus genome type 7b",
            "authors": [],
            "year": 1980,
            "venue": "Am J Epidemiol",
            "volume": "112",
            "issn": "5",
            "pages": "619-628",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF185": {
            "title": "Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission",
            "authors": [],
            "year": 2015,
            "venue": "J Clin Microbiol",
            "volume": "53",
            "issn": "2",
            "pages": "746-749",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF186": {
            "title": "Adenovirus type 7 outbreak in a pediatric chronic-care facility\u2014Pennsylvania, 1982",
            "authors": [],
            "year": 1983,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "32",
            "issn": "19",
            "pages": "258-260",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF187": {
            "title": "Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period",
            "authors": [],
            "year": 1994,
            "venue": "J Clin Microbiol",
            "volume": "32",
            "issn": "9",
            "pages": "2321-2323",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF188": {
            "title": "Adenovirus type 7 infections in children in New South Wales, Australia",
            "authors": [],
            "year": 1989,
            "venue": "J Med Virol",
            "volume": "29",
            "issn": "1",
            "pages": "28-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF189": {
            "title": "Adenovirus type 7b in a children's hospital",
            "authors": [],
            "year": 1983,
            "venue": "J Infect Dis",
            "volume": "147",
            "issn": "5",
            "pages": "814-819",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF190": {
            "title": "Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir",
            "authors": [],
            "year": 2007,
            "venue": "Transpl Infect Dis",
            "volume": "9",
            "issn": "2",
            "pages": "108-113",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF191": {
            "title": "Outbreak of severe infection due to adenovirus type 7 in a paediatric ward in Japan",
            "authors": [],
            "year": 1998,
            "venue": "J Hosp Infect",
            "volume": "39",
            "issn": "3",
            "pages": "207-211",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF192": {
            "title": "Adenovirus serotype 7 associated with a severe lower respiratory tract disease outbreak in infants in Shaanxi Province, China",
            "authors": [],
            "year": 2011,
            "venue": "Virol J",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF193": {
            "title": "Outbreak of adenovirus serotype 8 conjunctivitis in preterm infants in a neonatal intensive care unit",
            "authors": [],
            "year": 2012,
            "venue": "J Hosp Infect",
            "volume": "80",
            "issn": "2",
            "pages": "144-149",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF194": {
            "title": "Human adenovirus type 8: the major agent of epidemic keratoconjunctivitis (EKC)",
            "authors": [],
            "year": 2014,
            "venue": "J Clin Virol",
            "volume": "61",
            "issn": "4",
            "pages": "477-486",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF195": {
            "title": "Abrupt emergence of diverse species B adenoviruses at US military recruit training centers",
            "authors": [],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "196",
            "issn": "10",
            "pages": "1465-1473",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF196": {
            "title": "Adenovirus infection of a renal allograft",
            "authors": [],
            "year": 2003,
            "venue": "Am J Kidney Dis",
            "volume": "41",
            "issn": "3",
            "pages": "696-701",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF197": {
            "title": "Pharyngo-conjunctival fever; school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14",
            "authors": [],
            "year": 1957,
            "venue": "BMJ",
            "volume": "2",
            "issn": "5037",
            "pages": "131-136",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF198": {
            "title": "Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007",
            "authors": [],
            "year": 2009,
            "venue": "J Infect Dis",
            "volume": "199",
            "issn": "10",
            "pages": "1419-1426",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF199": {
            "title": "A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14",
            "authors": [],
            "year": 2009,
            "venue": "J Infect Dis",
            "volume": "199",
            "issn": "10",
            "pages": "1427-1434",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF200": {
            "title": "First reported cases of human adenovirus serotype 14p1 infection, Ireland, October 2009 to July 2010",
            "authors": [],
            "year": 2011,
            "venue": "Euro Surveill",
            "volume": "16",
            "issn": "8",
            "pages": "1-5",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF201": {
            "title": "Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation",
            "authors": [],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "9",
            "pages": "1290-1297",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF202": {
            "title": "Association of type 21 adenovirus with acute respiratory illness in military recruits",
            "authors": [],
            "year": 1962,
            "venue": "Am J Hyg",
            "volume": "76",
            "issn": "",
            "pages": "149-159",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF203": {
            "title": "Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985",
            "authors": [],
            "year": 1986,
            "venue": "J Clin Microbiol",
            "volume": "24",
            "issn": "6",
            "pages": "1084-1088",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF204": {
            "title": "Hospital-associated epidemic of pharyngitis and conjunctivitis caused by adenovirus (21/H21 + 35)",
            "authors": [],
            "year": 1986,
            "venue": "J Infect Dis",
            "volume": "154",
            "issn": "4",
            "pages": "706-709",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF205": {
            "title": "Adenovirus 21 infection in an isolated antarctic station: transmission of the virus and susceptibility of the population",
            "authors": [],
            "year": 1991,
            "venue": "Am J Epidemiol",
            "volume": "133",
            "issn": "6",
            "pages": "599-607",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF206": {
            "title": "Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia",
            "authors": [],
            "year": 2003,
            "venue": "Clin Infect Dis",
            "volume": "36",
            "issn": "5",
            "pages": "550-559",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF207": {
            "title": "Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak",
            "authors": [],
            "year": 1999,
            "venue": "Lancet",
            "volume": "354",
            "issn": "9183",
            "pages": "987-991",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF208": {
            "title": "Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature",
            "authors": [],
            "year": 2004,
            "venue": "Am J Transplant",
            "volume": "4",
            "issn": "12",
            "pages": "2102-2108",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF209": {
            "title": "Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation",
            "authors": [],
            "year": 2005,
            "venue": "Br J Haematol",
            "volume": "130",
            "issn": "4",
            "pages": "595-603",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF210": {
            "title": "Description of an adenovirus A31 outbreak in a paediatric haematology unit",
            "authors": [],
            "year": 2006,
            "venue": "Bone Marrow Transplant",
            "volume": "38",
            "issn": "1",
            "pages": "23-28",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF211": {
            "title": "Adenovirus type F subtype 41 causing disseminated disease following bone marrow transplantation for immunodeficiency",
            "authors": [],
            "year": 2005,
            "venue": "J Clin Microbiol",
            "volume": "43",
            "issn": "3",
            "pages": "1462-1464",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF212": {
            "title": "Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene",
            "authors": [],
            "year": 2006,
            "venue": "Arch Virol",
            "volume": "151",
            "issn": "8",
            "pages": "1587-1602",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF213": {
            "title": "An outbreak of acute respiratory disease in China caused by human adenovirus type B55 in a physical training facility",
            "authors": [],
            "year": 2014,
            "venue": "Int J Infect Dis",
            "volume": "28",
            "issn": "",
            "pages": "117-122",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF214": {
            "title": "Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study",
            "authors": [],
            "year": 2014,
            "venue": "Crit Care",
            "volume": "18",
            "issn": "4",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF215": {
            "title": "Molecular and serological characterization of species B2 adenovirus strains isolated from children hospitalized with acute respiratory disease in Buenos Aires, Argentina",
            "authors": [],
            "year": 2013,
            "venue": "J Clin Virol",
            "volume": "58",
            "issn": "1",
            "pages": "4-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF216": {
            "title": "Antigenic characterization of intermediate adenovirus 14-11 strains associated with upper respiratory illness in a military camp",
            "authors": [],
            "year": 1976,
            "venue": "Infect Immun",
            "volume": "13",
            "issn": "2",
            "pages": "354-359",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF217": {
            "title": "Genetic relationship between thirteen genome types of adenovirus 11, 34, and 35 with different tropisms",
            "authors": [],
            "year": 1991,
            "venue": "Intervirology",
            "volume": "32",
            "issn": "6",
            "pages": "338-350",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF218": {
            "title": "Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease",
            "authors": [],
            "year": 2007,
            "venue": "Clin Infect Dis",
            "volume": "45",
            "issn": "8",
            "pages": "958-965",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF219": {
            "title": "Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection",
            "authors": [],
            "year": 2004,
            "venue": "Clin Infect Dis",
            "volume": "38",
            "issn": "11",
            "pages": "1521-1525",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF220": {
            "title": "Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation",
            "authors": [],
            "year": 2010,
            "venue": "Leukemia",
            "volume": "24",
            "issn": "4",
            "pages": "706-714",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF221": {
            "title": "Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing",
            "authors": [],
            "year": 2004,
            "venue": "J Clin Microbiol",
            "volume": "42",
            "issn": "9",
            "pages": "3963-3969",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF222": {
            "title": "Molecular characterization of an adenovirus 3-16 intertypic recombinant isolated in Argentina from an infant hospitalized with acute respiratory infection",
            "authors": [],
            "year": 2010,
            "venue": "J Clin Microbiol",
            "volume": "48",
            "issn": "4",
            "pages": "1494-1496",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF223": {
            "title": "A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005",
            "authors": [],
            "year": 2008,
            "venue": "J Med Virol",
            "volume": "80",
            "issn": "1",
            "pages": "102-112",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF224": {
            "title": "Fatal adenovirus infection in a neonate and transmission to health-care workers",
            "authors": [],
            "year": 2009,
            "venue": "J Clin Virol",
            "volume": "45",
            "issn": "4",
            "pages": "345-348",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF225": {
            "title": "Identification of a novel intertypic recombinant species D human adenovirus in a pediatric stem cell transplant recipient",
            "authors": [],
            "year": 2014,
            "venue": "J Clin Virol",
            "volume": "61",
            "issn": "4",
            "pages": "496-502",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF226": {
            "title": "Antiadenovirus activities of several classes of nucleoside and nucleotide analogues",
            "authors": [],
            "year": 2005,
            "venue": "Antimicrob Agents Chemother",
            "volume": "49",
            "issn": "3",
            "pages": "1010-1016",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF227": {
            "title": "In vitro susceptibility of adenovirus to antiviral drugs is species-dependent",
            "authors": [],
            "year": 2005,
            "venue": "Antivir Ther",
            "volume": "10",
            "issn": "2",
            "pages": "225-229",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF228": {
            "title": "Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children",
            "authors": [],
            "year": 2002,
            "venue": "Pediatrics",
            "volume": "110",
            "issn": "1 Pt 1",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF229": {
            "title": "Safety and tolerability of cidofovir in high-risk pediatric patients",
            "authors": [],
            "year": 2009,
            "venue": "Transpl Infect Dis",
            "volume": "11",
            "issn": "4",
            "pages": "373-379",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF230": {
            "title": "Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro",
            "authors": [],
            "year": 2005,
            "venue": "J Infect Dis",
            "volume": "191",
            "issn": "3",
            "pages": "396-399",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF231": {
            "title": "Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model",
            "authors": [],
            "year": 2008,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "105",
            "issn": "20",
            "pages": "7293-7297",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF232": {
            "title": "Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model",
            "authors": [],
            "year": 2014,
            "venue": "Antiviral Res",
            "volume": "112",
            "issn": "",
            "pages": "38-46",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF233": {
            "title": "Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients",
            "authors": [],
            "year": 2012,
            "venue": "Biol Blood Marrow Transplant",
            "volume": "18",
            "issn": "5",
            "pages": "731-738",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF234": {
            "title": "Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001",
            "authors": [],
            "year": 2011,
            "venue": "J Clin Virol",
            "volume": "50",
            "issn": "2",
            "pages": "167-170",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF235": {
            "title": "Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years (1991-2007)",
            "authors": [],
            "year": 2010,
            "venue": "J Med Virol",
            "volume": "82",
            "issn": "4",
            "pages": "624-631",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF236": {
            "title": "CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation",
            "authors": [],
            "year": 2013,
            "venue": "N Engl J Med",
            "volume": "369",
            "issn": "13",
            "pages": "1227-1236",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF237": {
            "title": "Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation",
            "authors": [],
            "year": 2003,
            "venue": "Bone Marrow Transplant",
            "volume": "31",
            "issn": "6",
            "pages": "481-486",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF238": {
            "title": "Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children",
            "authors": [],
            "year": 2001,
            "venue": "Bone Marrow Transplant",
            "volume": "27",
            "issn": "6",
            "pages": "621-626",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF239": {
            "title": "Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program",
            "authors": [],
            "year": 2014,
            "venue": "Biol Blood Marrow Transplant",
            "volume": "20",
            "issn": "2",
            "pages": "250-256",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF240": {
            "title": "Adenovirus infection and treatment with cidofovir in children after liver transplantation",
            "authors": [],
            "year": 2009,
            "venue": "Pediatr Transplant",
            "volume": "13",
            "issn": "4",
            "pages": "421-428",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF241": {
            "title": "Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia",
            "authors": [],
            "year": 2008,
            "venue": "J Heart Lung Transplant",
            "volume": "27",
            "issn": "6",
            "pages": "699-700",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF242": {
            "title": "Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin",
            "authors": [],
            "year": 2010,
            "venue": "Transpl Infect Dis",
            "volume": "12",
            "issn": "1",
            "pages": "77-83",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF243": {
            "title": "High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy",
            "authors": [],
            "year": 2008,
            "venue": "Pediatr Transplant",
            "volume": "12",
            "issn": "2",
            "pages": "219-227",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF244": {
            "title": "Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients",
            "authors": [],
            "year": 2004,
            "venue": "Bone Marrow Transplant",
            "volume": "34",
            "issn": "10",
            "pages": "909-914",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF245": {
            "title": "Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery",
            "authors": [],
            "year": 2002,
            "venue": "Blood",
            "volume": "100",
            "issn": "5",
            "pages": "1619-1627",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF246": {
            "title": "New adenovirus species found in a patient presenting with gastroenteritis",
            "authors": [],
            "year": 2007,
            "venue": "J Virol",
            "volume": "81",
            "issn": "11",
            "pages": "5978-5984",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF247": {
            "title": "Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients",
            "authors": [],
            "year": 2005,
            "venue": "J Infect Dis",
            "volume": "191",
            "issn": "4",
            "pages": "520-530",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF248": {
            "title": "Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity",
            "authors": [],
            "year": 2005,
            "venue": "Bone Marrow Transplant",
            "volume": "35",
            "issn": "",
            "pages": "S73-S76",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF249": {
            "title": "Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT",
            "authors": [],
            "year": 2014,
            "venue": "Sci Transl Med",
            "volume": "6",
            "issn": "242",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF250": {
            "title": "Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant",
            "authors": [],
            "year": 2013,
            "venue": "Mol Ther",
            "volume": "21",
            "issn": "11",
            "pages": "2113-2121",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF251": {
            "title": "Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT",
            "authors": [],
            "year": 2015,
            "venue": "Blood",
            "volume": "125",
            "issn": "12",
            "pages": "1986-1994",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF252": {
            "title": "Emergence of adenovirus type 14 in US military recruits\u2014a new challenge",
            "authors": [],
            "year": 2007,
            "venue": "J Infect Dis",
            "volume": "196",
            "issn": "10",
            "pages": "1436-1437",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF253": {
            "title": "Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States",
            "authors": [],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "202",
            "issn": "1",
            "pages": "93-103",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF254": {
            "title": "A human adenovirus species B subtype 21a associated with severe pneumonia",
            "authors": [],
            "year": 2014,
            "venue": "J Infect",
            "volume": "69",
            "issn": "5",
            "pages": "490-499",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF255": {
            "title": "Molecular evolution of human adenoviruses",
            "authors": [],
            "year": 2013,
            "venue": "Sci Rep",
            "volume": "3",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF256": {
            "title": "Human mastadenovirus type 70: a novel, multiple recombinant species D mastadenovirus isolated from diarrhoeal faeces of a haematopoietic stem cell transplantation recipient",
            "authors": [],
            "year": 2015,
            "venue": "J Gen Virol",
            "volume": "96",
            "issn": "9",
            "pages": "2734-2742",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF257": {
            "title": "Designation of human adenovirus types based on sequence data: an unfinished debate",
            "authors": [],
            "year": 2013,
            "venue": "J Clin Virol",
            "volume": "58",
            "issn": "4",
            "pages": "743-744",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF258": {
            "title": "Adenoviruses in immunocompromised hosts",
            "authors": [],
            "year": 2008,
            "venue": "Clin Microbiol Rev",
            "volume": "21",
            "issn": "4",
            "pages": "704-715",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF259": {
            "title": "Molecular Epidemiology of Adenovirus Type 21 Respiratory Strains Isolated From US Military Trainees (1996-2014)",
            "authors": [],
            "year": 2015,
            "venue": "J Infect Dis",
            "volume": "212",
            "issn": "6",
            "pages": "871-880",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF260": {
            "title": "Adenovirus: current epidemiology and emerging approaches to prevention and treatment",
            "authors": [],
            "year": 2014,
            "venue": "Curr Infect Dis Rep",
            "volume": "16",
            "issn": "8",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF261": {
            "title": "Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000",
            "authors": [],
            "year": 2002,
            "venue": "Emerg Infect Dis",
            "volume": "8",
            "issn": "3",
            "pages": "269-277",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF262": {
            "title": "Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006-2007 epidemics in North America",
            "authors": [],
            "year": 2010,
            "venue": "Respir Res",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF263": {
            "title": "Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR",
            "authors": [],
            "year": 2006,
            "venue": "J Clin Microbiol",
            "volume": "44",
            "issn": "8",
            "pages": "2808-2815",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF264": {
            "title": "Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?",
            "authors": [],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "40",
            "issn": "9",
            "pages": "1244-1249",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF265": {
            "title": "Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP",
            "authors": [],
            "year": 2010,
            "venue": "J Clin Microbiol",
            "volume": "48",
            "issn": "4",
            "pages": "1438-1441",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF266": {
            "title": "Pharyngoconjunctival fever caused by adenovirus type 11",
            "authors": [],
            "year": 1992,
            "venue": "Pediatr Infect Dis J",
            "volume": "11",
            "issn": "1",
            "pages": "6-9",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF267": {
            "title": "Adenovirus type 11 epidemic conjunctivitis in Singapore",
            "authors": [],
            "year": 1974,
            "venue": "Southeast Asian J Trop Med Public Health",
            "volume": "5",
            "issn": "3",
            "pages": "333-341",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF268": {
            "title": "Epidemic haemorrhagic conjunctivitis associated with adenovirus type 11 in Taiwan",
            "authors": [],
            "year": 1974,
            "venue": "Southeast Asian J Trop Med Public Health",
            "volume": "5",
            "issn": "3",
            "pages": "342-349",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF269": {
            "title": "Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility\u2014Illinois, 2005",
            "authors": [],
            "year": 2007,
            "venue": "Clin Infect Dis",
            "volume": "45",
            "issn": "4",
            "pages": "416-420",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF270": {
            "title": "Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan",
            "authors": [],
            "year": 2009,
            "venue": "J Clin Microbiol",
            "volume": "47",
            "issn": "8",
            "pages": "2678-2679",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF271": {
            "title": "Characterization of culture-positive adenovirus serotypes from respiratory specimens in Toronto, Ontario, Canada: September 2007-June 2008",
            "authors": [],
            "year": 2009,
            "venue": "Virol J",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF272": {
            "title": "Adenoviruses associated with acute gastroenteritis in hospitalized and community children up to 5 years old in Rio de Janeiro and Salvador, Brazil",
            "authors": [],
            "year": 2007,
            "venue": "J Med Microbiol",
            "volume": "56",
            "issn": "Pt 3",
            "pages": "313-319",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF273": {
            "title": "Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients",
            "authors": [],
            "year": 2006,
            "venue": "J Med Virol",
            "volume": "78",
            "issn": "9",
            "pages": "1210-1217",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF274": {
            "title": "Adenovirus genome types isolated from stools of children with gastroenteritis in S\u00e3o Paulo, Brazil",
            "authors": [],
            "year": 1995,
            "venue": "J Med Virol",
            "volume": "45",
            "issn": "2",
            "pages": "127-134",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF275": {
            "title": "Molecular epidemiology of subgenus F adenoviruses associated with pediatric gastroenteritis during eight years in Hiroshima Prefecture as a limited area",
            "authors": [],
            "year": 2006,
            "venue": "Arch Virol",
            "volume": "151",
            "issn": "12",
            "pages": "2511-2517",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF276": {
            "title": "Molecular epidemiology of human astrovirus and adenovirus serotypes 40/41 strains related to acute diarrhea in Tunisian children",
            "authors": [],
            "year": 2009,
            "venue": "J Med Virol",
            "volume": "81",
            "issn": "11",
            "pages": "1895-1902",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF277": {
            "title": "High prevalence of species D human adenoviruses in fecal specimens from Urban Kenyan children with diarrhea",
            "authors": [],
            "year": 2010,
            "venue": "J Med Virol",
            "volume": "82",
            "issn": "1",
            "pages": "77-84",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF278": {
            "title": "Outbreak of acute gastroenteritis caused by adenovirus type 41 in a kindergarten",
            "authors": [],
            "year": 2011,
            "venue": "Epidemiol Infect",
            "volume": "139",
            "issn": "11",
            "pages": "1672-1675",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF279": {
            "title": "Characterizations of adenovirus type 41 isolates from children with acute gastroenteritis in Japan, Vietnam, and Korea",
            "authors": [],
            "year": 2004,
            "venue": "J Clin Microbiol",
            "volume": "42",
            "issn": "9",
            "pages": "4032-4039",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF280": {
            "title": "Epidemiology of acute viral gastroenteritis in children hospitalized in Rouen, France",
            "authors": [],
            "year": 2002,
            "venue": "Clin Infect Dis",
            "volume": "34",
            "issn": "9",
            "pages": "1170-1178",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF281": {
            "title": "Prevalence of enteric adenoviruses among children with diarrhea in four Brazilian cities",
            "authors": [],
            "year": 2002,
            "venue": "J Clin Virol",
            "volume": "23",
            "issn": "3",
            "pages": "171-177",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF282": {
            "title": "Adenovirus 7a: a community-acquired outbreak in a children's hospital",
            "authors": [],
            "year": 2000,
            "venue": "Pediatr Infect Dis J",
            "volume": "19",
            "issn": "10",
            "pages": "996-1000",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF283": {
            "title": "Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom",
            "authors": [],
            "year": 2010,
            "venue": "Emerg Infect Dis",
            "volume": "16",
            "issn": "1",
            "pages": "55-62",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF284": {
            "title": "Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens",
            "authors": [],
            "year": 2008,
            "venue": "Epidemiol Infect",
            "volume": "136",
            "issn": "1",
            "pages": "23-33",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF285": {
            "title": "Community respiratory viruses in individuals with human immunodeficiency virus infection",
            "authors": [],
            "year": 1997,
            "venue": "Am J Med",
            "volume": "102",
            "issn": "",
            "pages": "19-24",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF286": {
            "title": "Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia",
            "authors": [],
            "year": 1966,
            "venue": "N Engl J Med",
            "volume": "275",
            "issn": "16",
            "pages": "870-874",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF287": {
            "title": "Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody",
            "authors": [],
            "year": 1984,
            "venue": "Pediatr Infect Dis",
            "volume": "3",
            "issn": "3",
            "pages": "246-251",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF288": {
            "title": "Fatal type 3 adenoviral pneumonia in immunocompetent adult identical twins",
            "authors": [],
            "year": 2003,
            "venue": "Clin Infect Dis",
            "volume": "37",
            "issn": "10",
            "pages": "e142-e146",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF289": {
            "title": "Epidemic keratoconjunctivitis in a chronic care facility: risk factors and measures for control",
            "authors": [],
            "year": 1993,
            "venue": "J Am Geriatr Soc",
            "volume": "41",
            "issn": "11",
            "pages": "1177-1181",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF290": {
            "title": "Nosocomial adenovirus infection: molecular epidemiology of an outbreak",
            "authors": [],
            "year": 1993,
            "venue": "Pediatr Infect Dis J",
            "volume": "12",
            "issn": "11",
            "pages": "922-925",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF291": {
            "title": "Health care transmission of a newly emergent adenovirus serotype in health care personnel at a military hospital in Texas, 2007",
            "authors": [],
            "year": 2009,
            "venue": "J Infect Dis",
            "volume": "200",
            "issn": "11",
            "pages": "1759-1765",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF292": {
            "title": "Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting",
            "authors": [],
            "year": 2006,
            "venue": "J Infect Dis",
            "volume": "194",
            "issn": "7",
            "pages": "877-885",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF293": {
            "title": "The impact of adenovirus infection on the immunocompromised host",
            "authors": [],
            "year": 2003,
            "venue": "Rev Med Virol",
            "volume": "13",
            "issn": "3",
            "pages": "155-171",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF294": {
            "title": "Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes",
            "authors": [],
            "year": 2002,
            "venue": "J Virol",
            "volume": "76",
            "issn": "21",
            "pages": "10608-10616",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF295": {
            "title": "Hematuria due to adenoviral infection in bone marrow transplant recipients",
            "authors": [],
            "year": 2010,
            "venue": "Transplant Proc",
            "volume": "42",
            "issn": "9",
            "pages": "3729-3734",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF296": {
            "title": "Molecular epidemiology of human adenoviruses",
            "authors": [],
            "year": 1984,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "110",
            "issn": "",
            "pages": "191-220",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF297": {
            "title": "An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies",
            "authors": [],
            "year": 2008,
            "venue": "Pediatr Infect Dis J",
            "volume": "27",
            "issn": "5",
            "pages": "419-424",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF298": {
            "title": "Epidemic spread of adenovirus type 4-associated acute respiratory disease between U.S. Army installations",
            "authors": [],
            "year": 2000,
            "venue": "Emerg Infect Dis",
            "volume": "6",
            "issn": "4",
            "pages": "415-419",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF299": {
            "title": "High isolation rate of adenovirus serotype 7 from South Korean military recruits with mild acute respiratory disease",
            "authors": [],
            "year": 2007,
            "venue": "Eur J Clin Microbiol Infect Dis",
            "volume": "26",
            "issn": "7",
            "pages": "481-483",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF300": {
            "title": "Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees",
            "authors": [],
            "year": 2014,
            "venue": "BMC Infect Dis",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF301": {
            "title": "Outbreak of adenovirus 35 pneumonia among adult residents and staff of a chronic care psychiatric facility",
            "authors": [],
            "year": 1997,
            "venue": "J Infect Dis",
            "volume": "176",
            "issn": "3",
            "pages": "760-763",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF302": {
            "title": "An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management",
            "authors": [],
            "year": 1988,
            "venue": "Infect Control Hosp Epidemiol",
            "volume": "9",
            "issn": "9",
            "pages": "398-404",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF303": {
            "title": "Multiple cases of life-threatening adenovirus pneumonia in a mental health care center",
            "authors": [],
            "year": 1998,
            "venue": "Am J Respir Crit Care Med",
            "volume": "157",
            "issn": "2",
            "pages": "645-649",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF304": {
            "title": "Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center",
            "authors": [],
            "year": 2006,
            "venue": "Medicine (Baltimore)",
            "volume": "85",
            "issn": "5",
            "pages": "278-287",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF305": {
            "title": "Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital",
            "authors": [],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "5",
            "pages": "694-700",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF306": {
            "title": "Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11",
            "authors": [],
            "year": 2009,
            "venue": "J Clin Microbiol",
            "volume": "47",
            "issn": "3",
            "pages": "697-703",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF307": {
            "title": "Viruses and disease. 3. An outbreak of adenovirus type 7A in a children's home",
            "authors": [],
            "year": 1971,
            "venue": "Am J Epidemiol",
            "volume": "93",
            "issn": "5",
            "pages": "399-402",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF308": {
            "title": "Severe and fatal pneumonia in infants and young children associated with adenovirus infections",
            "authors": [],
            "year": 1958,
            "venue": "Am J Hyg",
            "volume": "67",
            "issn": "3",
            "pages": "367-378",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF309": {
            "title": "Worldwide epidemiology of human adenovirus infections",
            "authors": [],
            "year": 1983,
            "venue": "Am J Epidemiol",
            "volume": "117",
            "issn": "4",
            "pages": "455-466",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF310": {
            "title": "Clinical picture and epidemiology of adenovirus infections (a review)",
            "authors": [],
            "year": 1993,
            "venue": "Acta Microbiol Hung",
            "volume": "40",
            "issn": "4",
            "pages": "303-323",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF311": {
            "title": "Spread of adenovirus to geographically dispersed military installations, May-October 2007",
            "authors": [],
            "year": 2010,
            "venue": "Emerg Infect Dis",
            "volume": "16",
            "issn": "5",
            "pages": "769-775",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF312": {
            "title": "Sensitivity of human adenoviruses to different groups of chemical biocides",
            "authors": [],
            "year": 2004,
            "venue": "J Hosp Infect",
            "volume": "57",
            "issn": "1",
            "pages": "59-66",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF313": {
            "title": "Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis",
            "authors": [],
            "year": 2001,
            "venue": "Clin Infect Dis",
            "volume": "32",
            "issn": "10",
            "pages": "1423-1429",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF314": {
            "title": "Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012",
            "authors": [],
            "year": 2014,
            "venue": "Influenza Other Respi Viruses",
            "volume": "8",
            "issn": "3",
            "pages": "302-308",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF315": {
            "title": "Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection",
            "authors": [],
            "year": 2007,
            "venue": "Semin Respir Crit Care Med",
            "volume": "28",
            "issn": "2",
            "pages": "222-242",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF316": {
            "title": "Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature",
            "authors": [],
            "year": 2008,
            "venue": "Eur J Clin Microbiol Infect Dis",
            "volume": "27",
            "issn": "2",
            "pages": "153-158",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF317": {
            "title": "Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia",
            "authors": [],
            "year": 2014,
            "venue": "Chest",
            "volume": "145",
            "issn": "1",
            "pages": "79-86",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF318": {
            "title": "Factors predisposing to abnormal pulmonary function after adenovirus type 7 pneumonia",
            "authors": [],
            "year": 1984,
            "venue": "Arch Dis Child",
            "volume": "59",
            "issn": "10",
            "pages": "935-939",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF319": {
            "title": "Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children",
            "authors": [],
            "year": 1971,
            "venue": "J Clin Pathol",
            "volume": "24",
            "issn": "1",
            "pages": "72-82",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF320": {
            "title": "Persistence of adenovirus nucleic acids in nasopharyngeal secretions: a diagnostic conundrum",
            "authors": [],
            "year": 2010,
            "venue": "Pediatr Infect Dis J",
            "volume": "29",
            "issn": "8",
            "pages": "746-750",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF321": {
            "title": "Persistent adenoviral infection and chronic airway obstruction in children",
            "authors": [],
            "year": 1994,
            "venue": "Am J Respir Crit Care Med",
            "volume": "150",
            "issn": "1",
            "pages": "7-10",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF322": {
            "title": "Prospective characterization of protracted bacterial bronchitis in children",
            "authors": [],
            "year": 2014,
            "venue": "Chest",
            "volume": "145",
            "issn": "6",
            "pages": "1271-1278",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF323": {
            "title": "Adenovirus species C is associated with chronic suppurative lung diseases in children",
            "authors": [],
            "year": 2014,
            "venue": "Clin Infect Dis",
            "volume": "59",
            "issn": "1",
            "pages": "34-40",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF324": {
            "title": "Respiratory virus detection in nasopharyngeal aspirate versus bronchoalveolar lavage is dependent on virus type in children with chronic respiratory symptoms",
            "authors": [],
            "year": 2013,
            "venue": "J Clin Virol",
            "volume": "58",
            "issn": "4",
            "pages": "683-688",
            "other_ids": {
                "DOI": []
            }
        }
    }
}